The interplay between mitochondria-endoplasmic reticulum contacts and Alzheimer’s disease by Santos Leal, Nuno João
From the Division of Neurogeriatrics, 
Department of Neurobiology, Care Sciences and Society 
Karolinska Institutet, Stockholm, Sweden 
THE INTERPLAY BETWEEN       
MITOCHONDRIA-ENDOPLASMIC RETICULUM 
CONTACTS AND ALZHEIMER’S DISEASE 
 
Nuno João Santos Leal 
 
Stockholm 2019 
 
  
 
Cover: Neuronal landscape by Greg Dunn (http://www.gregadunn.com/) 
 
All published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by E-Print AB 2019 
© Nuno João Santos Leal, 2019 
ISBN 978-91-7831-389-1 
The interplay between mitochondria-endoplasmic 
reticulum contacts and Alzheimer’s disease 
 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
This thesis will be defended in Biomedicum 1, Biomedicum, Floor 3, Solnavägen 9, Solna 
Friday the 26th of April, 2019 at 9:30. 
By 
Nuno João Santos Leal 
Principal Supervisor: 
Professor Maria Ankarcrona 
Karolinska Institutet 
Department of Neurobiology,  
Care Science and Society 
Division of Neurogeriatrics 
 
Co-supervisor(s): 
Associate Professor Helena Karlström 
Karolinska Institutet 
Department of Neurobiology,  
Care Science and Society 
Division of Neurogeriatrics 
 
Professor Bengt Winblad 
Karolinska Institutet 
Department of Neurobiology,  
Care Science and Society 
Division of Neurogeriatrics 
 
Associate Professor Per Nilsson 
Karolinska Institutet 
Department of Neurobiology,  
Care Science and Society 
Division of Neurogeriatrics 
Opponent: 
Professor Christopher Miller 
King’s College London 
Department of Basic and Clinical Neuroscience 
 
 
 
Examination Board: 
Professor Bertrand Joseph 
Karolinska Institutet 
Department of Environmental Medicine 
Division of Toxicology 
 
 
Associate Professor Anna-Lena Ström 
Stockholm University 
Department of Biochemistry and Biophysics 
Division of Neurochemistry 
 
 
Associate Professor Eskil Elmer 
Lund University  
Department of Clinical Neurophysiology 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
’You can hide memories, but you can't erase the history.’ 
in Colorless Tsukuru Tazaki and His Years of Pilgrimage by Haruki Murakami 
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ABSTRACT 
Even though Alzheimer’s disease (AD) was first described more than 100 years 
ago, we still have no treatment preventing the ongoing neurodegenerative process. 
Two major pathological hallmarks have been connected to AD: extracellular amyloid 
plaques (constituted by amyloid β-peptide – Aβ) and neurofibrillary tangles. Several 
biological processes have been shown to be altered in AD including mitochondrial 
functions, autophagosome formation and calcium (Ca2+) homeostasis. Interestingly, 
all these processes have been shown to be regulated in mitochondria-endoplasmic 
reticulum contact sites (MERCS). Moreover, both the activity and the number of 
these contacts are affected in AD, which could explain the alterations of the biological 
processes mentioned above. However, it is still unknown if the alteration in MERCS 
causes the pathology or vice-versa. In this thesis, I have contributed to uncovering 
some of the mechanisms behind the interplay between MERCS and AD.  
• In Study I we show that the number of MERCS is increased in brain biopsies 
of demented patients and that there is a reversed correlation between MERCS 
and Mini Mental State Examination (MMSE) scores. In the same study, we 
show that the number of MERCS positively correlate with aging and ventricular 
Aβ42 levels; 
• In Study II we show that Aβ increases the number of MERCS in different 
models, leading to alteration in autophagosome formation and mitochondrial 
function; 
• In Study III we show that the increase of MERCS, through acute knock-down 
of Mitofusin 2, leads to decreased levels of both Aβ40 and Aβ42 due to 
impaired g-secretase assembly and activity; 
• In Study IV we show that the translocase of the outer mitochondrial membrane 
(TOM) receptor protein TOM70 modulates Ca2+ shuttling from ER to 
mitochondria via IP3R3 at MERCS.  
Altogether, these studies contributed to unravel the role of MERCS in AD. We 
show that MERCS dynamics changes throughout ageing and is accentuated in AD 
pathology, affecting several biological processes vital for overall cellular function. We 
believe this increase of MERCS could either trigger the neurodegenerative 
processes underlying AD or being an attempt to rescue neuronal dysfunctions. 
Moreover, MERCS modulation affects Aβ levels, which makes us believe that 
MERCS and Aβ regulate each other in a reciprocal manner. 
 
 
 
 
RESUMO 
Apesar da doença de Alzheimer (AD) ter sido primeiramente descrita há mais 
de 100 anos ainda não existem tratamentos que alterem o processo de 
neurodegeneração observado na patologia. Os dois principais marcadores 
moleculares associados com a doença são: placas amiloides no meio extracelular 
(constituídas maioritariamente pelo péptido β-amiloide - Aβ) e os novelos 
neurofibrilares no meio intracelular. Nos últimos anos, vários processos biológicos 
foram demonstrados estar alterados na AD incluindo função mitocondrial, 
metabolismo de fosfolípidos, formação de autofagossomas e homeostasia do cálcio 
(Ca2+). Curiosamente, todos estes processos são regulados pelos locais de contacto 
entre a mitocôndria e o retículo endoplasmático (ER) (MERCS). Além disso, foi 
demonstrado que estes contactos estão aumentados na AD, o que pode explicar a 
alteração dos processes biológicos referidos acima. No entanto, ainda está por 
determinar se as alterações nos MERCS causam a patologia ou vice-versa. Esta 
tese contribui para o esclarecimento de alguns dos mecanismos por detrás da 
interação entre os MERCS e a AD. 
• No Estudo I demonstrámos que o número de MERCS está aumentado em 
cérebros de pacientes com demência e que existe uma correlação inversa 
entre o número de MERCS e os resultados do Mini Exame do Estado Mental 
(MMSE). No mesmo estudo também demostrámos que o número de MERCS 
é directamente proporcional com a idade e os níveis ventriculares de Aβ42.  
• No Estudo II demonstrámos que o Aβ aumenta o número de MERCS em 
vários modelos, levando a alterações na formação de autofagossomas e 
função mitocondrial; 
• No Estudo III demonstrámos que o aumento de MERCS, através da redução 
dos níveis da protein Mitofusina 2, leva à diminuição dos níveis de Aβ40 e 
Aβ42 devido à alteração da conformação e actividade da g-secretase. 
• No Estudo IV, mostramos que o receptor TOM70 da translocase da 
membrana exterior mitocondrial (TOM) modula a transferência de Ca2+ do ER 
para a mitocôndria através da proteína IP3R3.  
De modo geral, estes estudos ajudam a esclarecer o papel dos MERCS na AD. 
Nós demostramos que a dinâmica dos MERCS é alterada durante o envelhecimento 
e é mais acentuada na AD, afectando vários processos biológicos vitais para a 
célula. Portanto, acreditamos que o aumento dos MERCS pode resultar no processo 
de neurodegeneração observado na AD ou resgatar a disfunção neuronal. Além 
disso, a modulação dos MERCS afecta os níveis do Aβ, o que nos faz crer que os 
MERCS e o Aβ controlam-se mutuamente através de um mecanismo de feedback. 
 
 
 
  
SAMMANFATTNING 
Trots att Alzheimers sjukdom (AD) först beskrevs för över 100 år sedan har vi 
fortfarande ingen behandling som påverkar den pågående neurodegenerativa 
processen. Två viktiga patologiska kännetecken har kopplats till AD: extracellulära 
amyloida plack (utgörs av amyloid β-peptid-Aβ) och neurofibrillära nystan. Flera 
biologiska processer har visat sig förändras i AD inklusive mitokondriella funktioner, 
autofagosombildning och kalcium (Ca2+) homeostasen. Intressant nog har alla dessa 
processer visat sig regleras i mitokondrie-endoplasmatiiska retikulets kontaktställen 
(MERCS). Dessutom har både aktiviteten och antalet av dessa kontakter visat sig 
öka i AD vilket skulle kunna förklara förändringarna av de biologiska processerna 
som nämnts ovan. Det är dock fortfarande okänt om förändringen i MERCS orsakar 
patologin eller vice versa. I denna avhandling har jag bidragit till att belysa några av 
mekanismerna bakom samspelet mellan MERCS och AD. 
• I Studie I visar vi att antalet MERCS ökar i hjärnbiopsier från dementa patienter 
och att det finns en inverterad korrelation mellan antalet MERCS och MMSE-
poäng. I samma studie visar vi att antalet MERCS positivt korrelerar med 
åldrande och ventrikulära Aβ42-nivåer. 
• I Studie II visar vi att Aβ ökar antalet MERCS i olika typer av djurmodeller vilket 
leder till förändring i autofagosombildning och mitokondriefunktion; 
• I Studie III visar vi att ökningen av antalet MERCS genom akut nedreglering 
av Mitofusin2 leder till minskade nivåer av både Aβ40 och Aβ42 på grund av 
nedsatt mognad och aktivitet av g-sekretaskomplexet. 
• I Studie IV visar vi att translokator av det yttre mitokondriella membranet (TOM) 
receptorn TOM70 modulerar Ca2+ transporten från ER till mitokondrier via 
IP3R3 vid MERCS. 
Sammantaget har dessa studier bidragit till att förstå MERCS:s roll i AD. Vi 
visar att MERCS-dynamiken förändras genom åldrande och accentueras med AD-
patologi, vilket påverkar flera biologiska processer som är viktiga för cellen. Vi tror 
att denna ökning av MERCS kan leda/bidra till den neurodegenerativa processen 
som pågår i AD eller rädda nervceller. Dessutom påverkar MERCS-moduleringen 
Aβ-nivåerna, vilket visar att MERCS och Aβ kontrollerar varandra på ett reciprokt 
sätt. 
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1 INTRODUCTION 
1.1 ALZHEIMER’S DISEASE 
“No matter how much suffering you went through, you never wanted to let go 
of those memories”, Haruki Murakami wrote. For Alzheimer’s disease (AD) patients, 
these memories unwillingly fade. Sadly, there is an awareness and a feeling of 
helplessness knowing that modern medicine still faces the same challenges as when, 
in 1901, Alois Alzheimer first described the disease.1 Today, after more than one 
hundred years, even though diagnostic techniques have improved and the molecular 
mechanisms underlying the pathology are better understood, there are still no 
available drugs that prevent the progression of the disease. Why have therapeutics 
in AD been so challenging? Many scientists are still battling this question. This thesis 
further uncovers the role of mitochondria-ER contact sites (MERCS), one of several 
affected processes of the pathology, in the origin/progression of AD. 
1.1.1 Definition and prevalence  
According to the World Health Organization (WHO), dementia is defined as 
“a syndrome – usually of a chronic or progressive nature – in which there is 
deterioration in cognitive function (i.e. the ability to process thought) beyond what 
might be expected from normal ageing. It affects memory, thinking, orientation, 
comprehension, calculation, learning capacity, language, and judgement.” 
(https://www.who.int) According to the WHO website “worldwide, around 50 million 
people have dementia, with nearly 60% living in low- and middle-income countries” 
and, since there are no drugs that affect the ongoing neurodegeneration, “the total 
number of people with dementia is projected to reach 82 million in 2030 and 152 in 
2050.” (https://www.who.int) 
AD is an example of these dementias. In fact, AD is the most common form 
of these mental disorders in the world and it is associated with lower quality of life, 
considerable suffering for both patients and families/caregivers, and economic 
burden on society. Similarly to the WHO’s definition of dementia, AD is described as 
a complex multifactorial neurodegenerative disease characterised by the decline of 
cognitive functions and loss of memory which can be associated with depression, 
confusion and aggressive behavior.2 For AD, the numbers today are around 50 
million cases worldwide but since this is a chronic ageing-related disorder and the 
  10 
world population’s life expectancy is increasing, the numbers are expected to 
augment to 1 in 85 people by 2050.3–5  
1.1.2 Aetiology and pathophysiological hallmarks 
Pathological hallmarks of AD include progressive loss of neurons 
(predominantly forebrain cholinergic neurons, and cortical and hippocampal 
glutamatergic neurons) and synapses. It also associated with accumulation of 
extracellular senile plaques [constituted of the amyloid β-peptide (Aβ)] in 
hippocampus and prefrontal, parietal and temporal cortices, and intracellular 
neurofibrillary tangles (NFT) (constituted of hyperphosphorylated tau protein) in 
hippocampus and entorhinal cortex.6–10  
Even though there is no consensus on AD aetiology, the most accepted 
hypothesis to explain the origin of the neurodegenerative process in AD is the intra- 
and extracellular accumulation of Aβ in the brain, denominated amyloid hypothesis. 
In fact, for many years it was thought that the amyloid plaques were responsible for 
the neuronal death observed in the pathology; however new evidences shows that 
the plaque formation may actually be a way for cells to deposit toxic Aβ 
extracellularly.11 Moreover, there is no correlation between the severity of cognitive 
impairment and plaque load. However, oligomeric forms of Aβ have been shown to 
be toxic both intracellularly and when applied extracellularly arising the idea that 
maybe these forms are responsible for the neuronal death.12–14 Although in this 
thesis I will mainly focus on the amyloid hypothesis, I am aware that AD 
pathogenesis is complex and also involves other alterations like oxidative stress, 
mitochondrial dysfunction, synaptic loss, alteration in cholesterol metabolism and 
inflammation leading, ultimately, to neuronal death.15,16 
1.1.3 Genetics and risk factors  
Two different subtypes of AD have been described: sporadic AD (SAD) and 
familial AD (FAD).7 While the exact aetiology of SAD is not known, FAD is caused 
by autosomal dominantly inherited mutations in the amyloid precursor protein (APP), 
presenilin 1 (PS1) or presenilin 2 (PS2). Although these mutations support the 
amyloid hypothesis (since they connect the pathology with the increased levels and 
aggregation of Aβ) they only account for 1% to 5% of the total AD cases. Moreover, 
FAD patients tend to have an earlier onset (from 30 years old) and more aggressive 
form of the disease when compared to SAD (with onset around 60 years old).17–19  
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Over 350 mutations have been found in APP, PS1 and PS2 and shown to be 
related to AD. (in https://www.alzforum.org/mutations) Relevant to this thesis are four 
mutations in the APP protein: London mutation (V717I), Swedish double mutation 
(KM670/671NL), Iberian mutation (I716F) and Artic mutation (E693G). All these 
mutations leads to an increase in the total Aβ levels except for the Artic mutation 
which increases the propensity of Aβ40 to aggregate, inducing the formation of 
protofibrils. (in https://www.alzforum.org/mutations)20–22 Although, the mentioned 
autosomal genetic mutations explain the aetiology of FAD, the reason behind the 
accumulation of Aβ in SAD remains unknown. However, known risk factors have 
been shown to increase the risk of developing SAD, including age, alcohol, smoking, 
diet; physical, cognitive and social inactivity; and the presence a specific allele of 
apolipoprotein E (ApoE). 19,23 ApoE is a component of lipoproteins that traffic lipids 
through blood, including in and within the brain, and the most common occurring 
allele variants is ApoE3. Carriers of variant ApoE4 show a significantly increased 
risk of developing AD than carriers of ApoE3 (2-3 fold if in one allele and up to 12-
fold if in both alleles).24  
1.1.4 Disease progression, diagnosis and treatment 
Despite the complexity of AD and the difference in onset, symptoms of both 
FAD and SAD are similar and include loss of short-term memory, decline of cognitive 
function (eg. language, decision making, abstract reasoning), incapability to perform 
at work and in social activities, changes in mood, and, ultimately, death commonly 
due to weakness, malnutrition and pneumonia.18 While, in the past, AD was usually 
diagnosed in advanced stages of pathology, we now know that the pathology starts 
up to 20-30 years before the first clinical symptoms. The development of new and 
more sensitive biomarkers in combination with neurological exams, results in 
migration of diagnosis to pre-symptomatic patients. Today, diagnosis of AD is based 
on both neurological and cognitive tests (like the Mini-Mental State Examination – 
MMSE) as well as brain structure using magnetic resonance imaging (MRI) and 
biomarker assessment including the detection of different forms of Aβ and tau in 
cerebrospinal fluid (CSF) or by positron emission tomography (PET).23,25,26 However, 
a definitive diagnosis of AD requires not only the clinical assessment but also a 
neurological examination of the post-mortem brain, to identify NFT and amyloid 
plaques.18 Even though early dementia diagnoses have increased over the past 
years, there is a lack of preventive strategies and pharmacological treatments that 
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stop the ongoing neurodegenerative processes in AD. Therefore, there is a need to 
identify the molecular mechanisms underlying the pathology to allow for new and 
improved diagnostic and therapeutic strategies to be developed.15 Treatment with 
acetylcholinesterase inhibitors and NMDA-agonist (memantine) results in slow down 
of the cognitive decline in patients with mild-to-moderate dementia, but does not 
modify the course of the illness.18 Recently, the traditional concept “one target, one 
treatment” has been questioned. After failure of over 100 clinical monotherapy trials 
targeting Aβ, multi-target therapies that address various aspects of AD are thought 
to be the solution.19 
1.1.5 Amyloid precursor protein and amyloid β-peptide 
1.1.5.1 Amyloid precursor protein, cleavage products and Aβ generation 
Aβ derives from the processing of amyloid precursor protein (APP).27 The 
physiological role of APP and its cleavage products remain largely undetermined, 
however suggested functions are connected to neurite outgrowth, synaptogenesis, 
neuronal protein trafficking along the axon, transmembrane signal transduction, cell 
adhesion and calcium (Ca2+) metabolism.28 Moreover, while some APP fragments 
are thought to be neuroprotective (e.g. sAPPα), others are considered to be 
neurotoxic (e.g. Aβ42), suggesting that net effect of full-length APP and its 
metabolites on cellular activity may be a combination of these metabolites’ functions, 
depending temporospatially on the proportion of levels of each APP metabolite.29  
Although several publications have described different processes involved 
in APP trafficking and processing, the whole process is still not fully understood and 
there is no consensus in the scientific community about the exact mechanism. Inside 
the cell, APP is expressed at high levels, quickly metabolised and can undergo two 
different cleavage pathways: the non-amyloidogenic and the amyloidogenic.4,30–32 In 
the first pathway APP is cleaved by α-secretase and g-secretase, forming p3, soluble 
APPα fragment (sAPPα), amyloid precursor protein intracellular domain (AICD) and 
C83; in the second pathway APP is cleaved by β-secretase (BACE1) and g-
secretase forming Aβ, soluble APPβ fragment (sAPPβ), AICD and C99 (Figure 1). 
β-secretase is constituted of the β-site APP cleaving enzyme (BACE1) and it has 
optimal function in acidic pH (like at endosomes and lysosomes).33 The g-secretase 
complex is constituted of four different proteins: presenilin 1 (PS1) or 2 (PS2), 
anterior pharynx-defective 1 (APH-1), Nicastrin (NCT) and presenilin enhancer 2 
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(PEN-2).34–37 The complex assembles and matures in the secretory pathway. APH-
1 and NCT form the initial scaffolding complex, stabilising PS1 (or PS2). PEN-2 
stabilises this complex by activating endoproteolysis of PS1 (or PS2).34–37 Both full-
length PS1 and PS2 undergo endoproteolysis in order to become proteolytically 
active, yielding the C-terminal fragment (CTF) and the N-terminal fragment (NTF) as 
by-products.38  
 
 
Figure 1. APP cleavage pathways. On the left the non-amyloidogenic pathway is shown where APP 
is first cleaved by α-secretase, forming C83 and sAPPα, and secondly by γ-secretase, forming p3 and 
AICD. On the right the amyloidogenic pathway where the first cleavage is performed by β-secretase, 
forming C99 and sAPPβ, and the second cleavage by γ-secretase, forming Aβ an AICD. Aβ can then 
form Aβ aggregates which will origin amyloid plaques observed in AD. 
 
Due to the different locations of the various secretases, APP and its 
metabolites, as well as the optimal activity of β-secretase in an acidic environment, 
it has not been possible to describe where exactly the generation of Aβ occurs. This 
processing is a complex mechanism that involves several steps and organelles and 
where and when precisely they all converge to form Aβ remains unknown. Although, 
one hypothesis is that APP is synthetized in the endoplasmic reticulum (ER) and 
subsequently transported to the Golgi apparatus where it undergoes post-translation 
modifications, such as glycosylation, phosphorylation and sulfation.39 In Golgi, APP 
can either be cleaved by α- or β-secretase.33 If not cleaved in this organelle APP is 
transported to the plasma membrane (via the secretory pathway) where it can be 
  14 
processed by α-secretase (which is enriched in the plasma membrane), forming the 
sAPPα and C83. APP that is not cleaved in the plasma membrane is endocytosed 
within minutes and recycled to the Golgi or to the lysosomes where it can be cleaved 
by β-secretase forming sAPPβ and C99. C99 is then delivered to the ER, via a 
currently unknown mechanism, where it is cleaved by the g-secretase complex, 
producing two peptides, Aβ and AICD while the C83, derived from the non-
amyloidogenic, forms the non-toxic p3 and AICD. In unaffected individuals, C99 is 
rapidly cleaved to Aβ40, which is ~ 40 amino acids (aa) in length. In AD, cleavage of 
C99 is shifted towards the aggregation prone Aβ42, which is ~ 42 aa in length, 
leading to the increased Aβ42:Aβ40 ratio, frequently observed in AD patients.40 
Interestingly, even though β-secretase follows similar trafficking routes as 
APP, they are not present in the same vesicles being unable to interact.41 These 
vesicles eventually interact when neuronal activity induces the convergence of these 
vesicles in recycling endosomes.42,43 Similarly, g-secretase has been detected in 
Golgi, endosomes and in other organelles like ER.44,45 Therefore, the cellular 
distribution of APP determines which secretase cleaves it and which cleavage 
products are generated. While accumulation of APP in the plasma membrane results 
in non-amyloidogenic processing, internalization of APP into acidic compartments 
leads to the formation of Aβ through the amyloidogenic pathway. In the beginning of 
2019, Liu and colleagues showed that β- and g- secretase form a super complex that 
is responsible for the majority Aβ production. Interestingly, they also showed that 
BACE1 and PS1 co-localized, with a stronger overlap in the perinuclear region where 
mitochondria and ER are relatively abundant.46–48 Recent studies report that β-
secretase, g-secretase and Aβ production occur in intracellular lipid rafts at 
mitochondria-ER contact sites (MERCS).52–55 This will be further developed in 
subheading 1.5.1 - β-secretase, γ-secretase, Aβ formation and MERCS. 
Previously, PS, APP, β- and g-secretase have been reported to be present in lipid 
rafts of the PM, although the activity of g-secretase here is low.49–51 
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1.1.5.2 Aβ function and metabolism 
As mentioned before the two main forms of Aβ involved in AD are Aβ40 and 
Aβ42, the last one being more toxic and prone to aggregation. The aggregation of 
Aβ is determined not only by the relative proportion of Aβ species but also by their 
concentration, pH, temperature and ionic strength of the solution.15 Although Aβ 
seems to affect mostly neurons, this peptide is also produced in astrocytes, microglia 
and other organs besides the brain such as the kidney, heart and liver.15 Since Aβ42 
is more common in the brain while Aβ40 is more dominant in the peripheral tissues, 
this could explain why accumulation of Aβ is increased in the brain as compared to 
other peripheral tissues.15 
The formation of Aβ via subsequent cleavage by β- and g-secretase is widely 
accepted for neurons, however the mechanisms responsible for Aβ clearance are 
not fully elucidated. Intracellularly, Aβ can be cleaved either by insulin degrading 
enzyme (IDE) in the cytosol and endosomes or by the presequence peptidase (PreP) 
in the mitochondrial matrix. If not degraded intracellularly, Aβ is secreted 
extracellularly by synaptic vesicles, exosomes, and, surprisingly, 
autophagosomes.56–58 Extracellularly, Aβ can either be degraded by neprilysin at the 
plasma membrane or taken up by glia cells and macrophages. Moreover, there is 
also an efflux of Aβ into the peripheral circulation [through the blood brain barrier 
(BBB) and CSF].15,59,60 In the periphery, Aβ can be catabolised by leukocytes and 
hepatocytes, excreted via bile or urine or cleared by Aβ-binding proteins (eg. albumin, 
ApoE).15,61 Notably, it is discussed that whilst Aβ40 is mainly degraded intracellularly, 
Aβ42 is degraded extracellularly. Therefore, it is believed that failure of Aβ clearance 
(especially Aβ42) is an important cause of sporadic AD.62  
As described above Aβ is believed to be one of the causes of AD, however 
non-pathological functions have also been associated with Aβ such as: antioxidant 
and antimicrobial activity, activation of signalling proteins, modulation of cholesterol 
transport, transcription factor and kinase activation. 19,63,64 Aβ was also shown to 
regulate neuronal homeostasis (in picomolar concentrations) through stimulation of 
post-tetanic potentiation, long-term potentiation and presynaptic transmitter 
release.65 
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1.1.6 Tau protein 
The other major molecular hallmark of AD are NFT formed by the intracellular 
accumulation of hyperphosphorylated tau protein. Tau was first described in the 
1970s during a study involving microtubules, as one of the major components of the 
neuronal cytoskeleton. Nowadays, it is known that the main role of this protein is to 
assemble tubulin (the “building block” of the microtubules) into microtubules, 
regulating their stability. Microtubules are essential for neuronal homeostasis and 
function since they contribute to the their structural support and the normal 
morphology of the neurons and are involved in intracellular trafficking and cell 
division.66,67 The binding of tau to the microtubules is regulated by kinases and 
phosphatases and, it has been postulated, that in AD there is an up-regulation of tau 
phosphorylation (hyperphosphorylation) preventing tau from binding microtubules 
which could lead to disorganisation and collapse of the microtubule network.68,69 This 
hyperphosphorylation of tau is also believed to cause tau polymerisation and 
formation of fibrillary structures leading to generation of NFT.70,71 NFT are believed 
to cause cell dysfunction (eg. decrease in glucose, lipid metabolism, ATP synthesis 
and others) due to the alteration in the organelle distribution within the cell.72  
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1.2 MITOCHONDRIA 
Several organelles and biological processes have been shown to be affected 
in AD. One example of these affected organelles are mitochondria. If we imagine a 
cell as a city, mitochondria would be its powerhouse since they are the main source 
of energy in the cell, under the form of adenosine triphosphate (ATP). While primitive 
prokaryotic cells lived without mitochondria for around two billion years, eukaryotic 
cells are dependent on this organelle for cellular respiration and ATP production.  
1.2.1 Mitochondrial structure 
Structurally, mitochondria are constituted by two lipid bilayer membranes: the 
outer mitochondrial membrane (OMM) and the inner mitochondrial membrane (IMM). 
The compartment between the two membranes is called mitochondrial 
intermembrane space (IMS) whereas the innermost compartment is referred to as 
mitochondrial matrix (Figure 2). The structure and composition of each compartment 
defines its function.73  
The OMM, as the name suggests, is the outer membrane that encloses the 
organelle and gives the shape and morphology to mitochondria. It contains a high 
number of integral membrane proteins called porins which allow molecules and small 
proteins up to 5000 daltons to diffuse through the membrane, while larger proteins 
cross this membrane via the translocase of the outer membrane (TOM) complex.73 
Furthermore, OMM also contains other enzymes responsible for the elongation of 
fatty acids, oxidation of epinephrine and degradation of tryptophan.74 OMM has also 
an important role in cell death since its disruption leads to the leakage of IMS proteins, 
inducing cell failure and death.74  
The IMM is particularly impermeable to most metabolites and ions due to its 
phospholipid composition. Cardiolipin, the major phospholipid of IMM, is constituted 
of four fatty acid chains instead of the typical two. This feature is extremely important 
for mitochondrial function because it allows the generation of mitochondrial 
membrane potential (ΔΨm) during cellular respiration. Invaginations of the IMM, 
called cristae,  increase its surface area and it is where the complexes of the electron 
transport chains (ETC).73,75–77 These cristae can be remodelled according to the 
metabolic requirements of the cell and recently they have been connected to 
programmed cell death as they can release pro-apoptotic factors.78  
The IMS is the aqueous compartment in between the OMM and the IMM. The 
IMS regulates protein import from the OMM to the IMM or matrix and protons 
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pumped across the IMM by ETC activity are stored in the IMS until travelling back to 
the matrix, whilst powering ATP generation through the FOF1-ATP synthase.73,79 
Lastly, the matrix is the other aqueous compartment of mitochondria and it 
harbours mitochondrial DNA (mtDNA) and the proteins encoded by mtDNA are 
transcribed and translated by mitochondrial ribosomes. Furthermore, it is also in the 
matrix where the series of chemical reactions in the tricarboxylic acid (TCA) cycle 
occurs and where the reduced nicotinamide adenine dinucleotide (NADH) is formed 
as a by-product from the TCA cycle. 
1.2.2 Mitochondrial DNA  
Structurally, mtDNA is a circular double stranded DNA constituted of around 
17.000 base pairs, encoding 11 messenger RNAs (which give origin to 13 proteins), 
2 ribosomal RNAs (12S and 16S) and 22 transfer RNAs. Interestingly, the 13 
proteins with mtDNA origin all belong to complexes of the respiratory chain. Since 
the ETC complexes are comprised of 92 proteins, mitochondria-encoded proteins 
account for only a very small fraction whilst the majority of these are nuclear encoded. 
In addition, nuclear DNA encodes a further 35 proteins that are required for the 
assembly of the respiratory chain even though they are not part of the mature 
complexes themselves.80,81 The reason why not all mitochondrial proteins are 
nuclear encoded is not known, but it is believed to be related with regulatory features 
of mitochondrial functions (eg. mitochondrial membrane potential or redox status) 
that require the presence of mtDNA close to the respiratory chain.81,82 In humans, it 
has been thought for a long time that mtDNA has an exclusively maternal origin. 
However, rcently it was shown for the first time that in some cases paternal mtDNA 
can be passed on to the progeny.83 
1.2.3 Mitochondrial protein import and TOM machinery 
While mtDNA encoded proteins are transcribed and translated in the 
mitochondrial matrix, the majority of mitochondrial proteins are encoded in the 
nucleus, translated in the cytosol and transported into mitochondria.80,81 In order for 
mitochondrial proteins to be imported into mitochondria they require specific import 
signals in their polypeptide sequence. The most frequent mitochondrial import signal 
is a presequence that exists at the N-terminal end of the precursor protein. After 
being imported, this presequence is cleaved off to allow proper folding of the 
protein.84,85 In the matrix, this now free presequence can penetrate IMM and disrupt 
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mitochondrial ΔΨm, due to its biochemical nature. Therefore, they are further 
degraded by proteases such as presequence protease.86 
Upon reaching mitochondria, the precursor protein faces the first import 
machinery, the translocase of the outer membrane (TOM) complex. TOM complex 
is constituted by the receptors TOM20 and TOM70/71, the pore of the complex 
TOM40, TOM22 and the small assistance TOM proteins (TOM5, TOM6 and 
TOM7).87 The main function of TOM20 and TOM70/71 is to identify if the precursor 
proteins have the proper targeting signal (presequence) and serve as the initial 
docking and checkpoint station. These proteins have been described to perform 
similar functions but to bind to different subsets of precursor proteins. While TOM20 
mainly binds to the hydrophobic part of the N-terminal presequences, TOM70 and 
TOM71 mainly recognises the hydrophobic internal targeting signals.88–90 Upon 
recognition by TOM20 or TOM70/71, the precursor protein binds to TOM22 and 
TOM5 which allows its passage through TOM40, the central aqueous pore of the 
complex.91,92 Precursor proteins then cross IMS until they reach the translocase of 
the inner membrane 23 (TIM23) complex. The hydrophobic signals in the 
presequence will determine if a protein will permanence in the IMM by a stop transfer 
mechanism or if it gets translocated to the matrix.93,94 Unlike the import through the 
OMM, the transport from the TIM23 complex into the IMM or matrix is ΔΨm-driven. 
Depending on the type of presequence, TIM23 mediates the translocation of the 
precursor protein into the matrix or the integration into the IMM. Proteins translocated 
into the mitochondrial matrix have to go through a final machinery that is ATP-driven, 
the translocase-associated import motor (PAM). Curiously, IMS protein selection is 
performed in a different way. IMS proteins usually have a high-content of cysteines 
so, as they emerge from the TOM40 pore, they form disulfide bridges due to the 
oxidative environment, “arresting” the protein in the IMS (Figure 2).95  
1.2.4 Glycolysis and oxidative phosphorylation: ATP production 
ATP is produced mainly through two differences processes: glycolysis and 
mitochondrial oxidative phosphorylation (OXPHOS). In the majority of human cells, 
glucose undergoes glycolysis where it is partly degraded, producing pyruvate. Per 
cycle, glycolysis produces only a small amount of ATP and NADH when compared 
to OXPHOS. Pyruvate can then travel inside mitochondria where it interacts with 
coenzyme A (CoA) forming acetyl-CoA. Next, this molecule enters the tricarboxylic 
acid (TCA) cycle, producing a large amount of NADH and flavin adenine dinucleotide 
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(FADH2). Electrons prevenient from NADH and FADH2 are then passed along the 
ETC where the majority of ATP is produced by OXPHOS.73 
The ETC is constituted of four redox complexes present in the IMM: Complex 
I (NADH:ubiquinone oxidoreductase/NADH dehydrogenase), Complex II (Succinate: 
ubiquinone oxidoreductase/Succinate dehydrogenase), Complex III 
(Ubiquinol:Cytochrome c reductase), Complex IV (Cytochrome c oxidase). These 
complexes are responsible for pumping protons from the matrix into the IMS (except 
complex II), using the flow of electrons to drive this process. Through a reduction-
oxidation reaction, NADH (electron donor) transfers an electron to the Complex I 
(electron acceptor) while FADH2 (electron donor) transfers to the Complex II 
(electron acceptor). Then, through the electron carrier Ubiquinone (Q) transfer 
electrons to complex III and through cytochrome c they are transferred to Complex 
IV. In Complex IV, oxygen is the last acceptor of electrons and H2O is formed with 
this electron and protons from the matrix.73 The transfer of electrons through the 
different ETC complexes occurs due to consecutive increase of electronegativity of 
the acceptors. With the pumping of the protons, an electrochemical gradient 
(responsible for the creation of ΔΨm) is established due to the differences in charges 
and concentration of protons between IMS and matrix. Due to the impermeability of 
the IMM, protons cannot pass through this membrane so they travel back to the 
matrix through the channel of the complex V (FOF1-ATP synthase) inducing the 
rotation in the complex which induces phosphorylation of ADP and inorganic 
phosphate into ATP (Figure 2).73,96 
1.2.4.1 The Warburg effect 
Otto Warburg was the first to describe that cancer cells tended to perform 
aerobic glycolysis, even in the presence of oxygen and functional mitochondria, 
producing high amounts of lactate. Warburg realised that in order to prevent tumour 
grow he had to inhibit both glycolysis and OXPHOS (by removing glucose and 
oxygen) since the removal of just one of them was not enough.97 Nowadays it is 
known that the Warburg effect is associated not only with tumours but also with other 
proliferating or developing cells, including immortalised cell lines used commonly 
worldwide. These cells have shown an increased uptake of glucose and produce, 
like the tumours, high levels of lactate even in the presence of oxygen and fully 
functional mitochondria.98 It is important to keep in mind that several of the studies 
mentioned in this thesis do not take this effect into account, meaning that changes 
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in mitochondrial metabolism could be “masked” due to “understimulated” 
mitochondria. Curiously, neurons rely on OXPHOS to meet their energy demands 
and therefore it is believed that the Warburg effect should not be overly pronounced 
in these cells. In fact, astrocytes provide extra lactate to neurons.99 
 
 
Figure 2. Overview of mitochondrial functions relevant for this thesis. Mitochondrial protein import 
mechanism occurs via TOM and TIM23 complexes and energy production (in the form of ATP) formed 
through glycolysis, TCA cycle and oxidative phosphorylation in the respiratory chain. 
1.2.5 Mitochondrial dynamics: fusion and fission 
The mitochondrion is frequently represented as a static rod-like isolated 
organelle but, in fact, this organelle is extremely dynamic and forms an extensive 
network that extends throughout the cell. However, mitochondrial morphology can 
be very different according to particular cell types and tissues since this morphology 
is highly linked to the organelle function, metabolic demands and health state. This 
morphology of the mitochondria is controlled through dynamic cycles of fusion and 
fission (Figure 3).77,100–102 These alternations between fusion and fission protect the 
mitochondria from excessive Ca2+ levels, mutant mtDNA and oxidative damage, all 
of which can influence mitochondria function. However, during ageing and in 
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neurodegenerative disorders, an unbalance in mitochondrial dynamics is frequently 
observed, leading to an increase of fragmented mitochondria.103,104 
1.2.5.1 Fusion 
Several proteins have been reported to be involved in mitochondrial fusion 
among which mitofusin 1 (Mfn1), mitofusin 2 (Mfn2) and optic atrophy 1 (Opa1) are 
the most studied. While Mfn1 and Mfn2 are responsible for the fusion of the OMM, 
Opa1 is responsible for the fusion of the IMM. Mfn1 and Mfn2 present similar 
structures, compromising around 750 amino acids and containing a GTPase domain 
in their N-terminal region, while the C-terminal region is anchored to the OMM by 
transmembrane domains. Even though these two proteins are structurally identical, 
Mfn1 is thought to be crucial for mitochondrial docking and fusion while Mfn2 has a 
lower GTPase activity and it is thought to stabilise the interactions between 
mitochondria.105,106 For the fusion event, both proteins form homo- or heterodimers 
through their HR2 domains (Figure 3). Ablation of either Mfn1 or Mfn2 in mice is 
embryonically lethal and impairment of Mitofusins GTPase activity prevents 
mitochondrial fusion.107,108   
Opa1 is anchored to the IMM by the N-terminal transmembrane domains 
while the GTP-binding and GTPase effector domain are the C-terminal region facing 
the IMS (Figure 3). Opa1 exists in different isoforms due to alternative splicing and 
proteolytic cleavages. While the long form (L-Opa1) is involved in the fusion of the 
IMM, excessive accumulation of the short form (S-Opa1) can lead to mitochondrial 
fragmentation. S-Opa1 is a short soluble form (found in the IMS), derived from the 
cleavage of L-Opa1 by OMA1 and YE1L and is also involved in controlling cristae 
shape, together with mitochondrial contact site and cristae organizing system 
(MICOS).109,110 Genetic ablation of Opa1 leads to impairment of mitochondrial fusion, 
originating fragmented mitochondria. As for Mitofusins, Opa1-ablated embryos are 
not viable. 
1.2.5.2 Fission 
In addition, as in the fusion process, several proteins have been reported to 
be involved in mitochondrial fission but in this thesis, I will focus on dynamin-related 
protein 1 (Drp1). Upon stimuli, this cytosolic protein migrates to the OMM where it 
oligomerizes in a ring-like structure. As the fusion proteins mentioned before, Drp1 
is also a GTPase, and upon GTP binding a conformational change occurs in the 
protein, leading to the strangling of the OMM by the ring-like structure, causing 
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fission. Several proteins have been reported to recruit Drp1 to the OMM including 
Fis1 and Mff (Figure 3). Drp1 activity can be modulated by these receptors/adaptor 
proteins by, for example, influencing its GTPase activity.111 Thus, this allows the 
possibility of regulating Drp1 in response to different cellular energy states. Mice with 
neuronal Drp1 KO die after birth, showing increased mitochondrial fusion, abnormal 
mitochondrial distribution along the axon, reduced neurites and impaired synapse 
formation.112  
 
Albeit fission and fusion of mitochondria are extremely important in all cell 
types, they are essential for neuronal development, survival and function due to the 
high energy demand of these cells.113 Due to the morphology of neuronal cells, 
fusion and fission are crucial for mitochondrial proliferation and distribution in the 
entire cell, even in the longest axons and dendrites. In neurons, mitochondrial fusion 
facilitates mitochondrial movement across long distances while mitochondrial fission 
allows mitochondrial renewal, redistribution and proliferation into synapses and post-
synaptic terminals.103,114,115  
 
 
Figure 3. Representation of mitochondrial fusion and fission. Mitofusin 1 and 2 (Mfn1 and Mfn2) are 
involved in the OMM fusion and Opa1 in the IMM fusion. Drp1 is recruited to mitochondria by, for 
example, Fis1 and Mff which will lead to the constriction of mitochondria, leading to its fission. 
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1.2.6 Mitochondria quality control and mitophagy 
Under certain conditions, when mitochondria stop working properly and its 
ΔΨm is lost, this could lead to consequences for the whole cell, culminating in 
induction of apoptosis and cell death. Therefore, there are several mechanisms that 
work as mitochondrial quality control. Those include the previously described 
mitochondrial dynamics (fusion and fission) where mitochondrial errors are diluted 
within the mitochondrial network or repaired.103,116,117 When irreversibly damaged, 
impaired mitochondria are first separated from the rest of the network by fission and 
permanently eliminated by mitophagy.101 Mitophagy is a selective type of autophagy 
(further developed in the subheading 1.3.3.5 Autophagosome formation) where 
mitochondria are engulfed into a vesicle enriched in hydrolases 
(autophagolysosome), leading to the degradation of the organelle. Several 
mechanisms have been described to trigger mitophagy such as PINK1/parkin 
dependent mitophagy. In normal conditions PTEN-induced putative protein kinase 1 
(PINK1) is imported into mitochondria via TOM and TIM23 complexes. Upon 
integration in the IMM, PINK1 is cleaved by the presenilin-associated rhomboid-like 
protein (PARL).118 If the ΔΨm is disrupted, PINK1 is not imported into the IMM and 
PARL cannot cleave PINK1. In this case, PINK1 accumulates in the OMM, leading 
to the recruitment of Parkin. Parkin's E3 ubiquitin ligase activity is activated, 
modifying cytosolic and OMM proteins by adding poly-ubiquitin to them (eg. Voltage-
Dependent Anionic Channel 1 (VDAC1), TOM40, TOM70, Mfn1 and Mfn2).119–122 
These poly-ubiquitinated proteins are then found and recognised by p62/SQSTM1 
(p62) leading to the recruitment of the autophagy-related proteins and formation of 
the autophagosome (further developed in the subheading 1.3.3.5 Autophagosome 
formation).  
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1.2.7 Dysregulated mitochondrial function/structure and pathology 
Due to their pivotal role in regulating key cellular events, alterations in 
mitochondrial structure or function can have a major impact on normal cell 
homeostasis, leading to different disorders in humans. In fact, during ageing, 
mitochondria progressively becomes damaged and dysfunctional, leading to 
alterations in reactive oxygen species (ROS) production, protein folding and ATP 
production, and eventually cell death.123 These alterations can then be associated 
with disorders like cancer and diabetes mellitus type 2.102,124 Other mitochondrial 
disorders are associated with mutations in mtDNA (eg. myopathy, encephalopathy, 
lactic acidosis, and stroke-like episodes (MELAS) and lactic acidosis).102,125 
Mutations in proteins regulating mitochondrial dynamics also lead to neuropathies 
like Charcot-Marie-Tooth disease type 2A (mutation in Mfn2) and autosomal 
dominant optic atrophy (mutation in Opa1).126–129 
Considering their major role as energy producers, it is comprehensible that 
the most affected tissues upon mitochondrial dysregulation are the ones with the 
highest energy demand like the muscle, brain and heart.77,130 In fact, it is quite 
surprising that while the human brain weighs only 2% of the total body weight it 
consumes 20% of all the oxygen and glucose during a resting state.131 Nowadays, it 
is believed that the reason for this outstanding number is related to the fact that 
neurons rely mostly on complete oxidation of glucose via OXPHOS to produce 
energy (they are unable to switch to glycolysis if OXPHOS becomes limited) and the 
fact that they are unable to store glycogen (storage form of glucose).132 Therefore, 
mitochondria are extremely important to neurons due to their high energy demand 
which includes: maintaining ΔΨm, axonal and dendritic transport (that can be up to 
one meter in certain neurons), and the release and uptake of neurotransmitters.103,133 
Furthermore, due to the polarised morphology of neurons, mitochondrial distribution 
to axons and dendrites is essential for cell survival.103,134 
Mitochondria have also been extensively linked to AD and this relationship 
will be further developed in the subheading 1.5.2 Mitochondria, ER and MERCS 
dysfunction in Alzheimer’s disease. 
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1.3 ORGANELLE CONTACT SITES: FOCUS ON MITOCHONDRIA AND 
ENDOPLASMIC RETICULUM JUXTAPOSITION 
Organelles in eukaryotic cells were for many years thought to be well-defined 
membrane-enclosed components and separate entities. Historically, the majority of 
these organelle structures and functions were characterised, originating the 
impression that each organelle is a separate entity and exert a clear role for cell 
homeostasis. In 1977, upon the discovery of the clathrin-coated vesicles, cell 
biologists started realising that organelles communicate among themselves.135–137 
For example, the interplay between at least five organelles has been described to 
be needed for the synthesis of cholesterol: ER, Golgi apparatus, plasma membrane, 
mitochondria and nucleus.138 Nowadays, it is known that organelles form highly 
organised networks and that this communication between organelles is essential for 
organelle development and function. This inter-organelle communication can occur 
through different mechanisms, for example either through vesicles or through 
organelle contact sites. Organelle contact sites is a fairly new area in research but 
this field has been developing rapidly and several associated processes and 
mechanisms have already been revealed. In this thesis, I will focus on the interaction 
between ER and mitochondria. 
1.3.1 Mitochondria-ER contact sites and mitochondria-associated ER 
membranes 
Mitochondria-ER contact sites (MERCS) were first observed in 1952 in rat 
liver and the first mitochondria-associated ER membranes (MAM) isolations from 
subcellular fractionations were performed in 1958, 1963 and 1971.139–143 During this 
period, it was often interpreted that this juxtaposition was either an artefact of sample 
preparations or contaminations. In 1977, when Shore and Tata discovered that ER 
could be divided into two different fractions [rough ER (RER) and smooth ER (SER)] 
they, and other researchers, realised that mitochondria were attached differently to 
these different types of ER, being strongly connected with SER.144–146  
ER is one of the largest organelles in the cell, sometimes occupying half of 
the total membrane area of a cell. The principal functions of ER are the biosynthesis 
of proteins (in RER) and lipids (in SER).73,138 The rough appearance of RER is due 
to the attachment of ribosomes to the ER, which allows co-translation of 
transmembrane proteins. This process prevents protein misfolding by avoiding their 
release into the cytosol and exposing their hydrophobic content. It has been reported 
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that RER contains over 20 proteins that are absent in the SER, which are thought to 
help ribosomes bind to the ER.73 SER is not as common as RER and ultra-
structurally is characterised for not being associated with ribosomes. Unlike RER, 
SER possesses sites where transport vesicles carrying synthetised proteins and 
lipids bud off, called ER exit sites. These vesicles are then transported to other 
organelles (eg. Golgi apparatus) so the proteins can be further matured. Other SER 
functions include synthesis of steroid hormones from cholesterol, lipoproteins 
particles and phospholipids (phosphatidylcholine), and storage of Ca2+. The release 
and uptake of Ca2+ from the ER are involved in several rapid responses within the 
cell. This sequestration is possible due to the high concentration of Ca2+-binding 
proteins [eg. sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)] that pumps Ca2+ 
into the lumen at cost of ATP.73  
However, it was not until 1990 that MAM was first described and a specific 
function attributed to this cell domain. Indeed, Jean Vance showed that 
phosphatidylserine (PSer), phosphatidylethanolamine (PE) and phosphatidylcholine 
(PC) are synthetised in MAM, in the presence of mitochondria.147 Even though the 
terms MERCS and MAM have been used interchangeably but they do not represent 
the same thing. Therefore, I would like to point out some of the differences in the 
terminology. MERCS is often used when referring to the both OMM and ER, 
including the architecture and ultrastructural organisation of the contact. MERCS can 
be visualised by EM and is the physical platform where the processes occur. On the 
other hand, MAM has been given two meanings:  
• The biochemically distinct region of the ER that behaves like a lipid-raft domain 
and is in contact with OMM;138,148–150 
• The enriched ER and mitochondrial membranes fraction derived from 
subcellular fractionation. In other words, the biochemical essence of the 
MERCS.151,152  
In this thesis, I will refer to MAM as Jean Vance did when she first introduced 
the term in 1994, therefore referring to the lipid-raft domain of the ER. MAM is a 
specialised region of the ER membrane with a lipid raft composition allowing it to 
interact with the OMM. Even though it was previously believed that mitochondria 
mainly interact with SER we now know that both SER and RER form MERCS with 
the OMM. In fact, in both cases, the organelles can run parallel to each other for 
dozens of nanometres, always separated by a cleft. The amount of ER in contact 
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with mitochondria is highly dependent on the needs of the cell and its metabolic 
state.153 In HeLa cells, early phases of ER stress induce an increase of more than 
two-fold in the number of MERCS, while the exposure of RBL-2H3 cells to apoptotic 
stimuli decreased the average distance between ER and mitochondria from 28.2 nm 
to 20 nm.154,155 Another example was shown by Sood and colleagues when, upon 
loss of thr mTORC1 nutrient-sensing pathway, there was an increase of the proximity 
between ER and mitochondria from 14 nm to 20 nm and an increase of average 
length of contact from 145 nm to 270 nm, while the number of MERCS did not 
change.153 It is believed that the MERCS profile could be a distinct structure 
signature of different cell types and for each different metabolic state. For example 
while MERCS are typically absent in synapses of neurons of the dentate gyrus, in 
hepatocytes 25% of mitochondria have at least one MERCS and in HeLa cells this 
ranges between 5% and 20%.151,153,156 
Curiously, not many studies have made detailed analyses of the structure, 
number and length of MERCS, and even less studies have considered the distance 
(cleft) between ER and mitochondria. The general consensus is that an increase of 
the number and length of MERCS correlates with increased MERCS function, 
however it is still highly debated what may happen when the distance between ER 
and mitochondria increases or decreases. By transmission electron microscopy 
(TEM), Csordas and colleagues identified that the average distance for this cleft is ≈ 
10nm between SER and OMM and ≈ 25 nm between RER and OMM. After that, 
several publications have detected different distances between ER and mitochondria 
from 10 to 80 nm, distinguishing the contacts between close contacts (<30 nm) and 
long-distance contacts (>30 nm) (Figure 4).53,151,157 Recently, Giacomello and 
Pellegrini suggested that different distances between ER and mitochondria are 
related with different “types” of MERCS (with different functions) where the distances 
between the two organelles are regulated by different tethering and functional 
proteins (eg. from 15 nm for Ca2+ exchange between ER and mitochondria up to 50 
nm to accommodate the autophagosome biogenesis).151  
This juxtaposition between the ER and mitochondria is known to be transient 
and does not require fusion or overlap of membranes since crude mitochondria 
fraction treated with high salt concentration, detergents and short proteolysis 
disrupted these connections.151,154,158 Therefore, we now know that MERCS 
formation requires proteins since proteinases can cause separation of the organelles. 
154,159  
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Figure 4. Electron micrograph of mouse pyramidal cell (CA1) next to several myelinated neuronal 
projections. Neuron is represented in yellow, mitochondria in orange, cytoplasm in green, 
endoplasmic reticulum in red, pre-synaptic terminals in grey and myelin structures in violet. Four close 
contacts between mitochondria ER can be seen where ER is in close proximity with mitochondria 
(black arrows). 
1.3.2 Ultrastructure and tethering proteins of MERCS 
Several years after discovering MERCS, the scientific community is still 
struggling to identify the proteins involved in the tethering of both organelles in 
superior eukaryotic cells. Several publications have tried to identify MERCS-related 
proteins with different techniques, including proteomics. In 2013, Poston performed, 
for the first-time, proteomics in a subcellular fraction enriched in ER-mitochondria 
contacts from mouse brain. They identified 1212 proteins and observed that most of 
the proteins in this fraction were suggested to be proteins from mitochondria and ER, 
and to be involved in mitochondrial functions and OXPHOS.160 Two years later, Liu 
performed a similar study in rabbit skeletal muscle, identifying 459 proteins where 
almost 25% of these were also involved in cell metabolism.161 Recently, Wang and 
colleagues have increased these numbers, since they identified over 2800 MERCS-
proteins in both mouse and human testis, and around 2500 MERCS-proteins in 
mouse brain. In addition, they showed that these two tissues overlapped in 1993 
MERCS-related proteins.162 Two other studies have not only performed proteomics 
on untreated samples but they also compared MERCS-protein content during viral 
infection163, in diabetes164 and in caveolin-1 (pivotal regulator of cholesterol and 
component of MERCS) KO mice.165 The mentioned proteomic studies are very 
promising since they have identified hundreds of possible candidates that could be 
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involved in the tethering between ER and mitochondria. However, most of these 
candidate proteins still need to be validated, which can be difficult due to the 
complexity of finding proteins that are exclusively located in MERCS.166 However, 
by 2013, 75 proteins had been functionally connected to MERCS.167 Nowadays, after 
6 years, some new proteins have been identified and characterised but there are still 
several awaiting validation. Of these already identified and characterised proteins, 
some have been described to act as scaffolds, tethering the two organelles, while 
others perform biological functions and some can do both. In the next subsection, I 
will describe some of the most relevant MERCS-proteins for the MERCS 
ultrastructure. 
1.3.2.1 Saccharomyces cerevisiae (Yeast) 
In 2009, Kornmann and colleagues identified for the first time the ER-
mitochondria encounter structure (ERMES), using a genetic screen to isolate yeast 
mutants.168 ERMES is constituted of two OMM proteins (Mdm10 and Mdm34), one 
ER protein (Mmm1) and one cytosolic protein (Mdm12). All these proteins co-localize 
with MERCS and elimination of the ERMES complex lead to cell death. Moreover, 
elimination of any of the ERMES proteins decreased MERCS function connected to 
the conversion of PSer to PE and PC, suggesting that the ERMES formed a bridge 
between ER and mitochondria.168 However, in 2012 a similar study showed that 
elimination of ERMES did not affect this conversion of PSer to PE.169 Also, while the 
coupling between ER and mitochondria is dynamic and transient, the ERMES 
complexes are long-lived.156,166,168 Therefore, it was proposed that ERMES has a 
role in mitochondrial morphology rather than a role in tethering ER and 
mitochondria.166 The existence of orthologues of ERMES in mammalian cells is still 
unknown. 
1.3.2.2 Mfn1 and Mfn2 
In 2008, De Brito and colleagues showed, for the first time, the involvement 
of mitofusins in MERCS. They showed that the ER morphology was altered in mouse 
embryonic fibroblasts (MEF) cells lacking Mfn2 (Mfn2-/-) and that Mfn2 was present 
in subcellular fractions enriched in MAM-OMM. Using volume-rendered 3D 
reconstructions of z-axis stack of confocal images and in vitro interaction assays, 
they concluded that MEF Mfn2-/- cells showed less interaction between ER and 
mitochondria. They also showed that while Mfn1 was localised only in the OMM, 
Mfn2 localised to both the OMM and MAM. In addition, they reported that these 
 31 
 
proteins can form hetero- and homotypic complexes (Mfn1-Mfn2 and Mfn2-Mfn2, 
respectively), linking the two organelles (Figure 6).170 However, in 2012, Cosson 
and colleagues used TEM to evaluate if MERCS were altered in the same cells. 
Surprisingly, they reported an increase in the number of MERCS although the 
average length of MERCS was not changed.171 In 2015, Filadi and colleagues 
reported similar results. To confirm whether the decrease of MERCS in MEF Mfn2-/- 
was due to clonal modification, they compared both knock-out (KO) and transient 
knock-down (KD) of Mfn2 in MEF using TEM. Both conditions showed an increase 
of close contacts (cleft distance ≤ 15 nm) between ER and mitochondria when 
compared to controls. Furthermore, they addressed the discrepancy between the 
confocal microscopy data from De Brito et al. and the TEM data from Cosson et al. 
and Filadi et al.171–173 According to the authors, co-localization in fluorescence 
microscopy is affected by changes in organelle morphology. If the area of the 
organelles increased substantially more than the perimeter, this could result in an 
apparent decrease of ER-mitochondria tethering.173 In fact, upon Mfn2 ablation, 
mitochondrial fragmentation and swelling is observed, making the classical co-
localization methods (Mander’s and Pearsson’ coefficients) unsuitable. They further 
proved this by showing that there was an increase in Ca2+ shuttling from ER to 
mitochondria in Mfn2 KD cells, which was not observed in the original publication 
due to the decreased levels of mitochondria calcium uniporter (MCU).171,173,174 In 
Study III we further confirm Cosson et al. and Filadi et al. data since we similarly 
show that KD of Mfn2 in HEK293 cells overexpressing APPSwe also leads to an 
increase of MERCS length.174 Other reports have assessed this issue but still, as of 
today, the scientific community has not fully agreed on the exact role of Mfn2 in 
MERCS due to the inconsistency of the results obtained by different groups. Even 
though down-regulation of Mfn2 has been one of the most used methods to modulate 
MERCS over the last few years, the conclusions deduced from the available data 
should have considered both possible roles of Mfn2. 
1.3.2.3 VAPB and PTPIP51 
Vesicle-associated membrane protein-associated protein B (VAPB) and 
protein tyrosine phosphatase-interacting protein 51 (PTPIP51) were first described 
to interact with each other and to modify intracellular Ca2+ concentration in 2012.175 
Currently, they are one of the most well described and characterised tethering pair 
of MERCS (Figure 6). From the first publication, De Vos and colleagues showed 
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that VAPB was present in MAM and that different levels of PTPIP51 altered the co-
localization of VAPB with mitochondria. Furthermore, depletion of either one of the 
proteins leads to changes in Ca2+ levels.175 Two years later the same group showed 
that both WT and mutated Tar DNA-binding protein 43 (TDP-43) [a protein 
connected to amyotrophic lateral sclerosis/frontal temporal dementia (ALS/FTD)] 
disrupted MERCS and the interaction between VAPB and PTPIP51, via activation of 
glycogen synthase kinase-3β (GSK-3β).176  
1.3.2.4 Other MERCS modifying proteins 
Using bioinformatics and prediction software, Hirabayashi and colleagues 
identified PDZD8 (a functional orthologue of the ERMES protein Mmm1) as a 
possible MAM protein in metazoans. They identified that PDZD8 is located in MAM 
and not in the pure mitochondrial fraction. They also showed that PDZD8 is required 
for formation of MERCS since its ablation led to less interaction between ER and 
mitochondria and to less Ca2+ transfer from ER to mitochondria, leading to 
unbalanced Ca2+ dynamics in cortical neurons. The mitochondrial protein which 
interacts with PDZD8 remains to be discovered (Figure 6).177 
Transglutaminase Type 2 (TG2) is the most ubiquitous member of a large 
enzyme group that catalyses Ca2+-dependent post-translational modification of 
proteins, including protein-protein cross-linking, incorporation of primary amines into 
proteins and glutamine deamination. Recently it was reported that TG2 interacts with 
Glucose-regulated protein 75 (Grp75) and in its absence the interaction between 
Grp75 and inositol 1,4,5-tris-phosphate receptor (IP3R) 3 (IP3R3) was increased. 
Using proximity ligation assay (PLA), immunocytochemistry and TEM the authors 
showed that in the absence of TG2 there were less interactions between IP3R3 and 
VDAC1, less overlap between ER and mitochondria and a decrease of MERCS.178 
Curiously, unlike other MAM proteins, ATPase family AAA domain-
containing protein 3 (ATAD3) has been described as an intermembrane tethering 
protein. ATAD3 spans from IMM to OMM and interacts with MAM.179 
Phosphofurin acidic cluster sorting protein 2 (PACS-2) is a cytosolic protein 
that can modulate MERCS and depletion of this protein leads to decreased MERCS 
and to the block of apoptosis upon its induction.180,181 Still today, it is unknown if this 
protein is a modulator or a tethering protein in this subcellular region. Mammalian 
target of rapamycin complex 2 (mTORC2) has been reported to be present in 
MERCS and it can activate PACS-2 via Akt pathway.182 
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1.3.3 Biological processes in MERCS 
Several biological processes have been connected to MERCS. Here, I will 
describe some of the most studied and relevant ones for this thesis: mitochondrial 
dynamics, Ca2+ shuttling, apoptosis, phospholipid metabolism and autophagosome 
formation.  
1.3.3.1 Mitochondrial dynamics 
Interestingly, ER and MERCS have important roles in regulating 
mitochondrial dynamics. Recently, it was reported that ER defines the exact site 
where mitochondrial division occurs.183 Firstly, there is the formation of MERCS, as 
ER surrounds the mitochondrial fission site. This allows the ER protein inverted 
formin-2 (INF2) and the mitochondrial protein actin-nucleating (Spire 1c and Arp2/3 
complexes) to recruit actin-myosin assemblies. Next, Drp1 is recruited to the ER-
marked places by the recruiting proteins and mitochondria undergo fission.184,185 
Interestingly, this event is thought to be controlled by mitochondrial matrix molecules 
since the constriction of the IMM occurs before the constriction of the OMM. In fact, 
actively replicating mtDNA is present in these ER-associated mitochondrial 
constriction and division sites, suggesting it could have a role during mitochondria 
fission.186,187 
1.3.3.2 Ca2+ shuttling 
One of the major functions of MERCS it to regulate Ca2+ shuttling between 
ER and mitochondria. Ca2+ is one of the most ubiquitous secondary messengers in 
the cell. Even small changes in intracellular Ca2+ concentrations mediate rapid 
response events, leading to drastic changes in cell functions (eg. muscle contraction, 
neuronal impulse and protein folding).77,188,189 To allow these rapid and intense 
responses, Ca2+ levels in the cytosol are kept low by exporting this molecule to the 
extracellular milieu and by storing into different organelles (like ER). In response to 
specific stimuli, the existence of Ca2+ “hotspots” in the cell allows a precise 
spatiotemporal response to changes in Ca2+ levels. Upon stimuli, Ca2+ can be 
released from the different stores into the cytosol or by the opening of channels in 
the plasma membrane. Therefore, both Ca2+ concentrations and diffusion in the cell 
have to be highly regulated. 
ER has been shown to be the major Ca2+ storage within the cell.190 The 
majority of Ca2+ enters the ER from the cytosol via SERCA and is released by either 
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the ryanodine receptors or IP3Rs. Mitochondria, in turn, can also transiently buffer 
Ca2+ at a smaller scale by taking up Ca2+ from the cytosol and ER.190  
The process of Ca2+ shuttling from ER to mitochondria has been well 
described. Firstly, Ca2+ is discharged from the ER via IP3R3 and shuttled to the IMS 
via VDAC1 supported by Grp75 (Figure 6).156,191 Three different types of IP3Rs 
receptors have been described: IP3R1, IP3R2 and IP3R3. IP3R3 has been shown 
to be highly enriched in MAM and therefore I mostly refer to the isoform 3 throughout 
this thesis.192 Similarly, VDAC has different isoforms being VDAC1 the most 
abundant.193 VDAC1 is a porin permeable not only to Ca2+ but also to energy-related 
metabolites like succinate, malate, pyruvate, NADH, ATP, ADP and phosphate, 
which are essential to keep mitochondrial homeostasis.194,195 From the IMS, Ca2+ 
crosses the IMM into the mitochondrial matrix via MCU.196 Due to the extreme 
impermeability of the IMM this is the rate limiting step of the entire shuttling process. 
Moreover, this also means that this shuttling requires an active OXPHOS and 
electrochemical gradient.197,198 Interestingly, MCU has a very low affinity for Ca2+ 
which prevents the uptake of Ca2+ into mitochondria when the levels in the cytosol 
are low.199,200 Therefore, the formation of Ca2+ hotspots is essential to guarantee that 
Ca2+ concentration is higher around MCU so it overcomes its low affinity.201 Since 
prolonged overflow of Ca2+ into the mitochondrial matrix could lead to initiation of 
apoptosis, Ca2+ cations are removed from mitochondria by mitochondria 
sodium/Ca2+ exchanger (NCLX) and taken up into ER again via SERCA.202 Since 
IP3R3, Grp75 and VDAC1 proteins are enriched in MERCS, it is believed that this is 
the major Ca2+ shuttling system for transfer of the cation from ER to mitochondria. 
Several proteins have been shown to modulate IP3R3-Grp75-VDAC1 protein 
complex, eg. Sigma-1 receptor is an ER resident chaperone that stabilises IP3R3 in 
MAM, prolonging the Ca2+ signalling between ER and mitochondria.203,204 Another 
example is TOM70. In Study IV of this thesis we show that knock-down of TOM70 
leads to reduction of Ca2+ shuttled from ER to mitochondria due to changes in the 
location of IP3R3 at MAM. This knock-down led to changes in mitochondrial 
respiration, cell number and autophagosome formation.205 Using different artificial 
linkers with different sizes and tags for ER and mitochondria it was shown that the 
closer the organelles are the more efficient the uptake of Ca2+ by mitochondria is 
and vice-versa, strengthening the hypothesis that Ca2+ shuttling occurs here.201  
Although Ca2+ is essential for mitochondrial functions, this organelle is highly 
sensitive to Ca2+ variations in the cation concentration due to several Ca2+ sensitive 
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proteins in OMM, IMM and mitochondrial matrix.77,189 In fact, the constant shuttling 
of small amounts of Ca2+ from ER to mitochondria is essential to maintain 
mitochondrial function and ATP production. When the levels of Ca2+ are moderately 
increased in the mitochondria matrix, this leads to the activation of several 
dehydrogenases (eg. pyruvate dehydrogenase (PDH), alfa-ketoglutarate 
dehydrogenase, isocitrate dehydrogenase) in the TCA cycle, boosting ATP 
synthesis (Figure 6).155,166,206,207 One way that Ca2+ regulates PDH activity is through 
controlling its phosphorylation (inactive PDH) by PDH kinase and dephosphorylation 
(active PDH) by Ca2+ activated phosphatase.77 However, prolonged overflow of Ca2+ 
into mitochondria leads to activation of programmed cell death mechanisms 
(expanded in the subheading 1.3.3.3 Apoptosis) (Figure 6). On the other hand, 
decrease of Ca2+ shuttling leads to a decrease in oxidative phosphorylation and 
cellular energy crisis.208,209  
Therefore, regulation of Ca2+ levels and mitochondrial functions are closely 
connected. While, Ca2+ regulates mitochondrial function (and dynamics), 
mitochondria buffers local increase of Ca2+ levels and guides the molecule through 
the cell to coordinate cellular processes. This is extremely important for excitable 
cells like muscle fibres and neurons, which rely on Ca2+ to fulfil their main functions 
and require a strict spatiotemporal regulation.77 
1.3.3.3 Autophagosome formation 
Autophagosomes were first observed in the 1950s when several experts in 
electron microscopy found vesicles containing cytoplasmic organelles in different cell 
types but, it wasn’t until 1963, that Christian de Duve introduced the term 
autophagy.210 Nowadays, several types of autophagy have been described; some 
are specific (like mitophagy) and some are non-selective (like macroautophagy).211 
Macroautophagy, most commonly referred to as autophagy, has been widely studied 
and it is currently known that it is an intracellular degradation/recycling process that 
is highly conserved in eukaryotic cells and is essential for cell homeostasis and 
development. During specific stresses (like starvation), autophagy is activated and 
cytosolic material (such as proteins and/or organelles) is engulfed by a double-
membrane structure, forming the autophagosome. This process allows the 
generation of free amino acids so they are available for protein translation in the 
stressed environment. The autophagosome is further matured and fused either with 
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multivesicular bodies or with the endosomal-lysosomal system, where the cargo can 
be degraded by lysosomal proteases.  
Autophagosome formation can be divided in three phases: initiation, 
nucleation and expansion. Different proteins/pathways have been described to 
control autophagy initiation. One example is the mammalian target of rapamycin 
complex 1 (mTORC1). Under basal conditions mTORC1 is active, promoting cell 
growth and anabolic processes (eg. macromolecules synthesis), and inhibiting 
autophagy through several phosphorylation on unc-51-like kinase 1 (ULK1) complex. 
Another example is the AMP-activated protein kinase (AMPK). AMPK is activated in 
situations where levels of ATP decrease and the levels of ADP and AMP increase. 
Under starved conditions active AMPK stops anabolic processes and induces 
catabolic pathways, like autophagy, induced by inhibition of mTORC1 complex and 
phosphorylation and activation of ULK1 complex. ULK1 activity is then regulated 
according to the phosphorylation status of its different residues, either by mTORC1 
or AMPK (Figure 5).211,212 
The activation of ULK1 complex will results in the formation of the isolation 
membrane via PI3KC3 complex that, together with several autophagy-related (ATG) 
proteins, leads to the maturation and formation of autophagosomes (Figure 6). 
Microtubule-associated protein 1A/1B-light chain 3 (LC3B) is one of these proteins. 
LC3B is an ubiquitin-like protein that is synthesised in an unprocessed form 
(proLC3B). This form of LC3B is cleaved in its C-terminus into LC3B-I and then 
conjugated to PE forming LC3B-II. While other ATG proteins dissociate from the 
autophagosomal membrane before the closure of the isolation membrane, LC3B-II 
remains attached to both the inner and outer membrane of the autophagosome. 
Upon fusion with the lysosome, the LC3B-II in the inner membrane is degraded while 
the one in the outer membrane is recycled. Therefore, LC3B-II has been widely used 
to monitor autophagy since, unlike other proteins, it remains attached to the mature 
autophagosomes.211–213 In order for LC3B to bind to the substrates that needs to be 
degraded (the cargo), proteins such as SQSTM1/p62 (p62) act as linkers between 
the ubiquitinated cargos and LC3B. Since p62 is captured together with the cargo 
and degraded in the autophagosome it can also be assessed as an index of 
autophagic activity, especially when autophagy is inhibited leading to p62 
accumulation (Figure 5).  
Even though many of the proteins involved in autophagosome 
formation/maturation has been identified, it is still unknown exactly where the 
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membrane that originates autophagosomes (isolation membrane) arises from. Since 
the autophagosome formation is a fast process, it is believed that the cell has to be 
able to mobilise a substantial amount of membranes upon autophagosome inducing 
stresses. Although different studies have shown that the isolation of the membrane 
that originates autophagosomes can originate from Golgi214,215, the plasma 
membrane 216 and even mitochondria217, it is believed that the ER is the main source 
of the isolation membrane.211 In 2003, Hamasaki and colleagues showed that upon 
starvation, ATG14L, DFCP1 and ATG5 were present in MAM-OMM enriched 
fractions, showing for the first time that autophagosome formation occurs at MERCS. 
They also showed that upon modulation of MERCS, by knocking-down of PACS2 
and Mfn2, the number of autophagosomes was decreased.218 This work was further 
confirmed by Garofalo and colleagues.219 Recently, the MERCS tethering complex 
VAPB-PTPIP51 has also been shown to regulate autophagosome formation. 
Gomez-Suada and colleagues showed that decreased levels of these proteins led 
to the increased formation of autophagosomes and vice-versa. They also showed 
that this was connected to Ca2+ shuttling between ER and mitochondria.220 Last year, 
another group showed that depletion of VAPA/B inhibits autophagy by impairing the 
maturation of the isolation membrane into autophagosome. They also showed that 
VAPA and B are recruited to the autophagosome formation sites during autophagy 
induction and that they interact with ULK1 and focal adhesion kinase family 
integrating protein (FIP2000), stabilising the ULK1/FIP200 complex.221  
Interestingly, not only MAM seems to be essential for the formation of 
isolation membrane but also Ca2+ signalling has been shown to affect autophagy 
formation. Both mTORC1 and AMPK have been shown to be modulated by Ca2+ 
levels and thus different agents that alter Ca2+ signals have consequences in 
autophagosome formation and/or maturation.222 Thapsigargin, for example, inhibits 
SERCA pump, preventing Ca2+ uptake from the cytosol to the ER leading to 
increased levels in the cytosol, triggering autophagy while chelating Ca2+ leads to 
autophagy inhibition.222 Furthermore, also Ca2+ signalling in mitochondria has an 
important role in autophagosome formation. As mentioned before, shuttling of Ca2+ 
into the mitochondrial matrix is tightly regulated. Correct amounts of Ca2+ boost ATP 
production, while high concentrations lead to cell death. Besides, a decrease of Ca2+ 
shuttling from ER to mitochondria affects negatively affects the TCA cycle and ATP 
production and can lead to the activation of autophagy. AMPK activity is regulated 
by AMP:ATP ratio in the cell. During normal conditions the AMP:ATP ratio is low 
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(increased ATP levels), ATP binds to AMPK allowing phosphatases to 
dephosphorylate AMPK, thus making it inactive. On the other hand, increased levels 
of AMP:ATP lead to AMP binding to AMPK, protecting its phosphorylated form, 
making AMPK active.223 Therefore, in conditions where Ca2+ shuttling to 
mitochondria is impaired, ATP levels drop, activating AMPK and inducing 
autophagosome formation, either through mTORC1 or ULK1/2 pathways.222,224 
Likewise, inhibition of IP3Rs using Xestospongin B, genetic knock-down, inhibition 
of IP3 production or mitochondrial Ca2+ uptake resulted, in basal conditions, in 
decreased mitochondrial Ca2+ and ATP production, triggering mTORC1-
independent autophagy.208,225 Curiously, treatment with Xestospongin B under 
starved conditions inhibited autophagy. Therefore, it is believed that IP3Rs-Ca2+ 
signalling can be pro-autophagy during normal conditions while in chronic starvation 
it acts anti-autophagy (Figure 5).226 Although the underlying mechanisms have not 
been unravelled, I personally think this is connected with MERCS. In order for 
autophagosomes to be formed, ATP is needed in different steps of the process, 
including initiation and progression.227–229 Under basal conditions, where ATP is 
available, acute abolishment of Ca2+ shuttling to mitochondria induces cell stress 
and a decrease in ATP levels. However, conditions will still allow formation of 
autophagosome since there is still ATP available. During chronic starvation, due to 
the lack of nutrients, cells are already stressed, and the levels of ATP have probably 
dropped below normal. Therefore, the connection between ER and mitochondria is 
needed in order to shuttle Ca2+ to mitochondria so a boost of ATP in formed under 
this stress condition and allow autophagosome formation. Inhibition of this shuttling 
during starvation, through treatment with Xestospongin B, will then prevent the 
formation of ATP and, consequently, autophagosomes.  
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Figure 5. Schematic representation of MERCS affects autophagosome formation. Increased Ca2+ 
shuttle from ER to mitochondria leads to increase of ATP formation, which leads to inhibition of AMPK. 
Decrease in AMPK activity, on its turn, can either decrease ULK1/2 activity or increase mTORC1 
activity. Ultimately, this results in induction of autophagy. 
1.3.3.4 Apoptosis 
As mentioned before, overload of Ca2+ into mitochondria can trigger 
apoptosis. Apoptosis, or programmed cell death, is a process where cells are 
eliminated in a structured manner. This mechanism is important for tissue 
development, to keep homeostasis by maintaining cell population, as a defence 
mechanism in immune responses and when cells are damaged.230 Apoptosis can be 
induced by two different pathways: death receptor (extrinsic) or mitochondrial 
(intrinsic).230,231 Most of the stimuli that trigger the mitochondrial apoptotic pathway 
induce changes in the IMM which, ultimately, leads to the opening of the 
mitochondria permeability transition (MPT) pore, loss of ΔΨm and release of pro-
apoptotic factors to the cytosol (eg. cytochrome c, Smac/DIABLO, serine protease 
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HtrA2/Omi) which leads to activation of the caspase-dependent mitochondrial 
pathway. 230 Overload of Ca2+ has been shown to have several effects on 
mitochondria but ultimately it sensitises mitochondria, lowering the threshold for MPT 
pore opening.231,232 Several lines of evidence have connected apoptosis to MERCS 
and increase of Ca2+ levels in mitochondria. Two independent publications showed 
that an increase of mitochondrial Ca2+ (through increase of MERCS) leads to an 
increase of apoptosis in RBL-2H3 cells and neurons.154,233  
1.3.3.5 Phospholipid and lipids metabolism 
The majority of organelles in the cell are surrounded by at least one phospholipidic 
monolayer. Since different lipids present distinctive features, alteration of these can 
lead to drastic changes in organelle function and integrity. Most of these 
phospholipids are generated in the ER and are distributed to the respective 
organelles by mechanisms that are still not completely known. Since phospholipids 
present long hydrophobic tails, they cannot be freely transported through the cytosol 
alone. Therefore, two options arise: they are either transported by vesicles or directly 
transferred to the target organelles through ER contact sites. As mentioned before, 
Vance and colleagues described in 1990 that certain phospholipids are formed in 
MERCS.147,166 MAM is a lipid “raft”-like sub-region of the ER that shares several 
characteristics with bulk ER, including the presence of several proteins involved in 
lipid and phospholipid metabolism. Although, some of these common proteins are 
more enriched in bulk ER others are more enriched in MAM [eg. phosphatidylserine 
synthase-1 and -2 (PSS1/2)].147,148,166 Although only a few proteins have been 
identified as a MAM specific protein as they are absent in bulk ER and mitochondria 
[(eg. phophatidylethanolamine-N-methyltransferase-2 (PEMT)].234 PE is the major 
phospholipid constituent of the IMM and it has been reported to be formed by 
decarboxylation of phosphatidylserine (PSer) in mitochondria.166 PSer is synthetize 
in the ER by MAM-enriched proteins PSer synthetase-1 and -2 (PSS1 and PSS2). 
PSer is then transported from the ER to the IMM where PSer decarboxylase (PSD) 
is located, forming PE which is shuttled back to ER. PE can then be converted to PC 
by PEMT and be shuttle back to mitochondria. Both PSS1 and PSS2 are highly 
enriched in MAM when compared to the bulk ER which suggests that PSer is 
synthesised and directly transported to mitochondria and not directly by cytosolic 
proteins or small vesicles.166,235,236 Although, the exact mechanisms remain 
unknown. 
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Figure 6. Schematic representation of MERCS ultrastructure and biological processes relevant for this thesis: phospholipid metabolism, Ca2+ signalling, APP 
processing, autophagosome formation. It is also represented some proteins involved in the tethering between MAM and OMM. 
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1.4 THE ROLE OF MERCS AND MAM IN DIFFERENT PATHOLOGIES 
Due to all the biologic processes regulated at MERCS, alterations in these 
contacts structure and MAM function have been reported to be associated with 
different human diseases. In Table 1 I have illustrated some examples: 
 
Table 1 Examples of disorders associated with alterations of MERCS. 
 
Disorder 
Pathophysiological 
hallmarks 
Pathology mechanism MERCS role Ref. 
Parkinson’s 
disease 
Dopaminergic neurons 
from substantia nigra are 
lost. 
Tremors, bradykinesia, 
rigidity. 
Mutation in PINK1 and Parkin 
leads to increased levels of 
Drp1 and mitochondria 
fragmentation and decrease of 
mitochondrial mobility. 
Increase of 
mitochondrial Ca2+ and 
the average length of 
each contact, while the 
number of MERCS per 
mitochondrion were 
decreased. 
237–240 
ALS/FTD 
Motor neuron dysfunction 
and frontal lobe 
impairment and 
dementia. 
Deposits of TDP-43 fused in 
sarcoma (FUS) and dipeptide 
repeat proteins derived from 
C9ORF72 gene. 
Reduced MERCS by 
disruption VAPB-
PTPIP51. 
176,241,
242 
 
Cancer 
Evasion of apoptosis, 
sustain proliferative 
signalising, active 
invasion and metastasis 
and changes in 
metabolism. 
Increased levels of IP3R3 and 
VDAC1 were observed in 
glioblastomas and human 
papilloma virus-related cervical 
cancers. Decreased levels of 
Mfn2 were observed in gastric 
tumours. 
Alterations in MERCS; 
Several oncogenes and 
tumour suppressors 
have been shown to 
localise at MAM and 
OMM. 
192,243,
244 
 
Obesity and 
type 2 
diabetes 
Alterations in insulin 
resistance and/or insulin 
secretion. Constant 
hyperglycaemia if not 
treated. 
MERCS are altered in palmitate-induced insulin-
resistance HuH7 cell and in liver of both obese and 
diabetic mice. Diabetic mice treated with anti-diabetic 
drugs showed improved insulin sensitivity and restored 
MERCS. 
245,246 
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1.5 MERCS AND ALZHEIMER’S DISEASE 
As for the disorders presented in the previous section, also dysregulation of 
MERCS has been shown in AD. In this subsection, I will summarise the studies which 
over the years, contributed to establishing a relationship between AD and MERCS. 
1.5.1 β-secretase, g-secretase, Aβ formation and MERCS 
In the 2000’s, Aβ was shown to be present in mitochondria in AD post-mortem 
brain.247–249 However, whether Aβ was produced in mitochondria or translocated into 
mitochondria was still unknown. Between 2004 and 2011, our group and others 
described that APP, Aβ and g-secretase are present in the OMM and that Aβ could 
be imported into mitochondria via the TOM complex and receptor for advanced 
glycation end products (RAGE).247,250–253 However, it was still hard to explain how 
Aβ could be produced at the OMM since this membrane does not have the right 
biochemical environment to harbour these proteins (not a lipid raft) or to sustain β-
secretase activity (due to the need to acidic pH). Moreover, it should be kept in mind 
that some of the data is derived from models with artificial expressions of APP and 
Aβ, and it is known that overexpression of proteins can lead to misallocation of 
proteins within the cell.65  
 
It was not until 2009, when Area-Gomez and colleagues connected how APP 
processing and Aβ formation could occur so close to mitochondria. The authors 
identified, for the first time, that g-secretase proteins, including PS1 and PS2, and 
APP were enriched in MAM-OMM subcellular fraction derived from mouse brain. 
PS1 was also found in plasma membrane/Golgi fraction, as reported before, but it 
was more enriched in the MAM-OMM fraction. Furthermore, they also showed that 
PS1 was 5- to 10-fold more enriched in MAM than in bulk ER.54 Interestingly, g-
secretase was not only shown to be present here but also active, since AICD was 
found in MAM-OMM fraction but not in plasma membrane, pure mitochondrial and 
ER fraction. This data was further confirmed by co-localization between PS1 and 
fatty acid-CoA ligase 4 (FACL4, a MAM-enriched protein).54  
Three years later, the same authors hypothesised that MAM was a detergent-
resistant membrane and it has features of a lipid-raft, since APP, PS, Aβ and                    
g-secretase are enriched in lipid-rafts. Indeed, MAM was shown to be an intracellular 
detergent-resistant membrane and VDAC1 and PS1 integrity was not affected after 
treatment with Triton X-100. The authors also showed that the amount of cholesterol 
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in MAM was higher than in bulk ER and pure mitochondria. Furthermore, they 
observed that MEF cells lacking PS1 and/or PS2 showed an increase in total 
cholesterol, free cholesterol and cholesteryl esters when compared to WT. 
Interestingly, PS1 and PS2 double KO cells had a higher increase in these lipids, 
compared to single KO, showing that both PS can influence the formation of the 
cholesterol and other related molecules. To support these evidences, not only was 
phospholipid synthesis augmented in double KO cells but also in SAD and FAD 
patient-derived fibroblasts, including PSer indicating an increase in MERCS. Later, 
they observed that there is an increase in co-localization between mitochondria and 
ER, using fluorescence microscopy and, using TEM, an increase in long contacts 
(>200 nm length) and decrease in short contacts (<50 nm) in both PS dKO MEF and 
SAD/FAD-derived fibroblast. Lastly, they showed that Mfn2 KO MEF cells had a 
decrease in C99 and AICD levels.53 Study III in this thesis confirms this data since 
we showed that acute knock-down of Mfn2 causes a decrease in Aβ levels.174 
However, while Area-Gomez and colleagues did not assess MERCS ultrastructure 
and assumed there was a reduction in MERCS, our assessment showed an increase 
of MERCS length. We know now, also from Gomez-Suaga and colleagues, that an 
increase of number and length of MERCS does necessarily represent an increase 
in MERCS-functions/activity.174,220  
To further confirm the role of MERCS in Aβ metabolism we showed that a 
considerable amount of both Aβ40 and Aβ42 is formed in subcellular fractions 
enriched in MAM-OMM.52 In comparison, mitochondria produced a very small 
amount of the peptide, strengthening the hypothesis that mitochondria do not 
produce a significant amount of Aβ. Two years later, Del Prete and colleagues 
uncovered more of the mechanism. They showed that β-secretase, g-secretase, 
APP and Aβ are present and active in MAM-OMM-enriched fractions of SH-SY5Y 
cell lines, as well as in mouse brains. They further confirmed the location of these 
proteins and complexes in MERCS by showing that APP and its catabolites co-
localized with mitochondria and ER using fluorescence microscopy. Finally, they 
showed an increase in MERCS in SH-SY5Y overexpressing APP with the Swedish 
mutation. 52,255 Even though there are evidences that Aβ is produced in MERCS, it 
is still not fully understood how the active g-secretase is transported back to MERCS 
from the Golgi or endosomes. However, it has been shown that endosomes, under 
certain conditions, are in contact with mitochondria256 and that the retrieval receptor 
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Rer1p has a role in transporting back the active g-secretase from the Golgi to the ER, 
suggesting that active g-secretase could actually be present in MAM.257,258  
1.5.2 Mitochondria, ER and MERCS dysfunction in Alzheimer’s disease 
Even though it is widely accepted that the major hallmarks of AD are the 
amyloid plaques and NFTs, many other alterations have been connected with the 
disorder: altered Ca2+259, glucose260, fatty acid261, cholesterol 262 and phospholipid263 
homeostasis and metabolism, autophagosome formation and maturation264,265 and 
mitochondria dysfunction.266 Interestingly, all of these cellular functions have been 
connected to MERCS, as described previously. Additionally, MERCS have been 
described to be up-regulated in different non-neuronal AD models or in primary 
neuronal cultures incubated with a mix of Aβ species.54,55,255 This, together with the 
role of MERCS in Aβ metabolism gave rise to the idea that MERCS alteration can 
be connected with AD.54,167,267 Under the next subheadings, I will describe in more 
detail the affected biological processes relevant to this thesis: Ca2+ homeostasis, 
mitochondria dysfunction, autophagosome formation/maturation and, even though 
not relevant for this thesis, phospholipid and cholesterol metabolism since it was the 
trigger of the field and several publications have focused on these processes.  
1.5.2.1 Ca2+ homeostasis 
Although the exact mechanisms that lead to alterations in Ca2+ homeostasis 
in AD are unknown, however several studies have connected PS and Aβ as possible 
causes of this dysregulation. Since ER is the major Ca2+-storage in the cells, it is 
believed that this organelle plays an important role under conditions of impaired 
Ca2+ homeostasis. Several evidences have emerged and tried to explain how PS 
can modulate Ca2+-homeostasis in the cell. In the early 90’s, Ito and colleagues 
showed that fibroblasts derived from asymptomatic members of AD families with PS 
mutation showed enhanced Ca2+-release from the ER.268 In fact, cells and tissues 
from animal models with mutated PSs were shown to activate IP3Rs, inducing Ca2+-
release.269270,271  This was further confirmed when it was shown that reducing IP3R1 
expression was able to rescue the exaggerated levels of Ca2+ in neurons and 
attenuated the Aβ and tau accumulation.272 Another theory is that PSs can interact 
with SERCA, inducing overflow of Ca2+-uptake into the ER273 or inhibiting it.274 More 
recently, Zampese and colleagues showed that, in SH-SY5Y cells and primary 
cortical neurons, the PS2-T122R mutation induces an increase in MERCS.275 This 
increased connectivity between the two organelles led to an up-regulation of MERCS 
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functions, such as increased Ca2+-shuttling from ER to mitochondria.53,275 
Interestingly, a new study from the same group showed that PS2 acts as a regulator 
of Mfn2, being able to “capture” Mfn2 and consequently regulate the contacts formed 
at MERCS.157 Cells overexpressing WT PS2, but not PS1, showed an increase in 
MERCS, but only in the presence of Mfn2. Curiously, PS2 FAD mutation 
exacerbated these connections. However, Mfn2 antagonistic effect was independent 
of PS2. Moreover, PS2 and Mfn2 were shown to physically interact with each other 
while interaction with PS1 and Mfn1 was not observed. Therefore, I believe that PS2 
can modulate Aβ formation not only through its pivotal role in g-secretase but also 
by modulating MERCS.  
Aβ, both extracellular and intracellular, has been shown to induce Ca2+-
dysregulation. For example, extracellular Aβ oligomers promotes influx of 
extracellular Ca2+ into the cell by forming Ca2+-permeable pores and by activating 
Ca2+-permeable channels.276,277 Furthermore, incubation of primary hippocampal rat 
neurons with oligomeric Aβ leads to increase apoptosis, increase cytosolic and 
mitochondrial Ca2+ and, recently, it was reported that it enhances shuttling of Ca2+ 
from ER to mitochondria as well as co-localization between ER and 
mitochondria.278,279 In addition, it was also reported that Aβ can induce Ca2+-release 
from the ER, either by formation of pores in the ER membrane or enhancing Ca2+-
release via IP3Rs and RyRs, inducing Ca2+ leakage from ER.280–282 Our group also 
showed that adding conditional media from CHO 7PA2 cells (enriched in different 
Aβ species) to WT primary cortical neurons upregulated the proximity between OMM 
protein VDAC1 and MAM protein IP3R3, as well as the shuttling of Ca2+ from ER to 
mitochondria.55 Therefore, this data shows that both Aβ and PSs can affect Ca2+ 
homeostasis via MERCS. 
1.5.2.2 Mitochondrial dysfunction 
Mitochondrial dysfunction has also been described as one of the earliest 
events in AD due to the accumulation of Aβ in mitochondria prior to plaque formation. 
Even though the exact mechanisms of how Aβ affects mitochondria are unknown, 
several publications have suggested some of the following mechanisms: early in the 
pathology it has been shown that there is a reduced number of mitochondria283; 
reduced activities of TCA cycle enzymes, OXPHOS and ATP production284; a 
decrease in glucose metabolism285 and an increase oxidative damage due to the 
augmented levels of ROS.16,286,287 The latter alteration has been linked to both 
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impairment of complex I, which is connected with ageing and inhibition of complex 
IV by Aβ.40,288,289 Increase of mitochondrial fragmentation has also been coupled to 
changes in the levels of mitochondrial dynamic proteins Mfn1, Mfn2, Opa1, Drp1 and 
Fis1.266 Additionally, mitochondrial axonal transport and re-distribution in the 
perinuclear region of the organelle has been shown in AD patients cells and cell lines  
as well as alteration in mtDNA and mitochondrial transcripts.40,266,290  
1.5.2.3 Autophagy  
During ageing, there is a decline of the proteasome-mediated turnover of 
proteins. This implies that the cells start relying more on the autolysosome system 
to degrade proteins.291 Recently it was shown that knock-down of Rubicon, a 
negative regulator of autophagy, increases lifespan and ameliorates age-associated 
phenotypes.292 In fact, knock-out of autophagy-related genes in neurons leads to 
neuronal death marked by the accumulation of ubiquitin-positive aggregates, 
showing that autophagy is essential for neuronal homeostasis.293,294 Most of the 
known autophagy mechanisms were identified in yeast and non-polarised 
mammalian cells and extrapolated to other types of cells. However, not much has 
been investigated in neurons nor neuronal cells. Since neurons are highly polarised 
cells it is believed that autophagy is regulated differently in these cells than in non-
neuronal cells.295–297. For several years it was believed that autophagy was inactive 
in neurons unless it was induced. Today, we know that this is highly unlikely. As far 
as the production rate matches or is below the clearance rate by lysosomal 
degradation, autophaghosomes are rarely observed, giving the impression that 
autophagosomes are not formed in neurons. This has been confirmed by inhibiting 
basal autophagy clearance by cathepsins, which led to a rapid accumulation of 
autophagic vacuoles (AVs) showing that neurons keep the number of 
autophagosome low in basal conditions.298,299  
The first evidences showing that autophagy was affected in AD were 
described by Nixon and colleagues when they observed autophagic vacuoles (AVs) 
in post-mortem AD brains, particularly within dystrophic neurites.265 The 
accumulation of these immature AVs suggested that the retrograde transport and 
maturation of autophagosomes with lysosomes was impaired in AD and, therefore, 
the elimination of Aβ was impaired.264,299 Curiously, these AVs were identified to 
contain full length APP, C99, PS1 and NCT, and to produce and accumulate 
intracellular Aβ.300,301 Interestingly, PS1 has been shown to also regulate autophagy 
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by modulation of the shuttling of v-ATPase subunit to the lysosome from the ER.302 
However, the exact role of autophagy in Aβ metabolism remains unclear. While 
some reports claim that formation of Aβ can occur in the autophagosomes, other 
reports showed that autophagy impairment leads to a decrease in Aβ secretion, 
resulting in a decrease in amyloid plaques and to intracellular accumulation of 
Aβ.57,301 In fact, pharmacological activation or inhibition of autophagy in SH-SY5Y 
leads to an increased in activity of α-, β- and g-secretase and extracellular Aβ42 
levels although g-secretase activity and extracellular Aβ42 levels were more 
enhanced during the inhibition of autophagosomes. Curiously, no differences were 
observed in Aβ-cleaving enzymes.303 In the same line of research, in Study II of this 
thesis, we show that models with high levels of Aβ show an increase in basal 
autophagy and that formation of autophagosomes occurs faster due to the increased 
in MERCS. Altogether, this data suggests a direct link between the amyloidogenic 
pathway and autophagy even though the exact mechanisms remain to be elucidated 
and different studies have shown contradicting results.  
1.5.2.4 Phospholipid and cholesterol metabolism 
As mentioned before, Area-Gomez and colleagues were pioneers in 
establishing a connection between MERCS and AD. While we and others have used 
mostly Ca2+ shuttling as a read-out for MERCS function, this group has focused on 
phospholipid and cholesterol metabolism. Recently, this group has shown that 
neuronal cells treated with astrocytes (APOE4) conditioned media showed an 
increased synthesis of PSer, PE and cholesteryl ester, and increase in co-
localization between ER and mitochondria when compared to cells treated with 
conditional media from astrocytes (APOE3). Even though the authors do not identify 
the mechanisms behind ApoE4 modulation of MERCS they believe it is related with 
lipoprotein metabolism pathway. They also claim that this could be the mechanism 
where ApoE4 acts as a risk factor in AD.304 The year after, the same authors showed 
that accumulation of C99 (by inhibition of g-secretase) in MAM resulted in the 
upregulation of sphingomyelin hydrolysis by sphingomyelinases, resulting in 
increased in ceramide levels, impaired mitochondrial respiration and blocking of 
ceramide reversed the bioenergetics impairments.305 
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1.5.2.5 MERCS in Tau models 
To the best of my knowledge, only two studies have connected tau protein 
to MERCS. In 2009, Perreault and colleagues showed that a mutant form of tau 
(JNLP3) increased the MERCS and, in 2018, Cieri and colleagues showed the same 
trend in the truncated caspase 3-cleaved 2N4RΔC20 tau protein, which induced 
fibrillation and seeding of WT tau.306,307  Therefore, the role of tau in MERCs remains 
largely unknown. In Study I of this thesis we touch a little bit upon this topic, where 
we observe that while no correlation is found between tau ventricular levels and 
MERCS there is a decrease in the length of MERCS in patients with plaques and 
NFT.308  
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2 AIM OF THE THESIS 
Altogether, the presented data strengthens the importance of mitochondria and 
MERCS in AD. Although several studies have established a connection between AD 
and MERCS ultrastructure and function, it is still unknown how MERCS alterations 
can lead to the pathology or how the pathology can lead to the alterations in MERCS, 
leading to the proverbial “the chicken or the egg” situation. The current state of the 
art in the field is: 
- Both mitochondria and MERCS structure and function as well as 
autophagosome formation/maturation are altered in AD; 
- APP, Aβ, β- and g-secretase are present in subcellular fractions enriched in 
MAM-OMM; Aβ is also formed here; 
- Autophagosomes form at ER-mitochondria contact sites and modulation of 
MERCS leads to changes in autophagosome biogenesis; 
- Alteration in MERCS dynamics alters mitochondrial Ca2+ content and its 
function and dynamics; 
- MERCS tethers in yeast are well described but in mammalian cells new 
scaffolds need to be further identified and explored, including regulator 
proteins; 
Therefore, the aim of this thesis was to further elucidate the connection between 
MERCS, Aβ metabolism and autophagosome formation in AD. The dysregulation of 
mitochondria-ER contact sites may be a key step and a possible target in the 
cascade of events leading to neurodegeneration in AD. 
 
The specific aims for each study were: 
- Study I: study MERCS ultrastrastructure in human brain biopsies and establish 
a correlation between MERCS ultrastructure in patient diagnosed with 
dementia and other clinical parameters.  
- Study II: study if Aβ affects MERCS ultrastructure and function in neuronal 
model, and how this led to changes in mitochondrial function and 
autophagosome formation. 
- Study III: study if modulation of MERCS altered Aβ levels. 
- Study IV: study if TOM70 has a role in MAM-OMM structure and function.
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3 METHODOLOGY AND METHODOLOGICAL 
CONSIDERATIONS 
 
3.1 MOUSE MODELS 
Several AD mouse models have been developed over the past. Most of these 
models were developed using the mutations associated with FAD. Recently, a new 
“generation” of animal models have emerged. While the “old” mouse models relied 
on overexpression of humanised APP and/or PS (with or without mutations), the new 
models tried to obliterate the secondary effects of protein overexpression (like 
mislocalisation of proteins and unspecific binding). The new models developed by 
Prof Takaomi Saido and Dr Takashi Saito rely on knock-in (KI) of humanised APP 
instead of its overexpression. In this thesis, we analysed the number of MERCS and 
length as well as number and perimeter of mitochondria in one overexpression 
transgenic model (APPSwe/Lon) and two KI models (APPNL-F and APPNL-G-F). The 
transgenic mouse model presented a humanised APP with both the Swedish and 
the London mutation (fixed tissue from the animals and respective controls were a 
kind gift of QPS Austria), while the KI model APPNL-F presented both the Swedish 
and Iberian mutation, and the model APPNL-G-F presented the same mutations plus 
the Artic mutation.   
In general, these mutations lead to increase production of Aβ (specifically Aβ42 
and Aβ40) except the Artic mutation (within the Aβ sequence), which increases the 
propensity and rate of Aβ40-aggregation. In Study II, in order to understand how the 
progression of the pathology could affect MERCS we analysed hippocampus (CA1) 
and cortex from animals of four (WT and APPSwe/Lon) and three (APPNL-F and APPNL-
G-F) different ages (2, 4, 6.5 and 10 months and 4, 6.5 and 10 months respectively), 
respectively (total of 48 animals). In brief, anesthetised animals were directly 
perfused with 2% glutaraldehyde and 1% formaldehyde in 0.1M phosphate buffer 
and brains dissected and hemisected. Right hemisphere was put in fixation solution 
overnight and the next day placed in brain slicer matrix and CA1 and cortex collected 
and processed for ultrathin sectioning for ultrastructural TEM. The rest of the brain 
was kept in fixative solution at 4°C. 
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3.2 HUMAN BRAIN BIOPSIES 
Idiopathic normal pressure hydrocephalus (iNPH) is a neurological disorder 
characterised by cognitive impairment as well as enlarged cerebral ventricles. Even 
though the mechanisms behind this pathology are unknown, this disorder shares 
comorbidity with AD, including the presence of the major AD hallmarks: amyloid 
plaques and NFTs.17,309 For further information about iNPH please refer to Williams 
et al.309 The only treatment available for iNPH is the introduction of a CSF shunt 
which alleviates the pressure and the symptoms.310 For Study I, cortical biopsies 
were obtained during this procedure as previously described.311 Briefly, the sample 
was collected from cortex, localised three centimetres laterally from the midline close 
to the coronal suture, and placed in fixative solution (1% glutaraldehyde and 3.7% 
formaldehyde in sodium phosphate buffer) up to 10 minutes after collection for TEM. 
Samples were then sectioned and stained with haematoxylin-eosin and immuno-
histochemistry performed with phosphorylated tau antibody (MN-1020, clone AT8 
IGH 135, Thermofisher) and Aβ (6F/3D, M0872; Dako) to check for and to 
characterize amyloid plaques and NFTs. Samples were then stratified in groups 
according to dementia diagnosis or absence/presence of amyloid plaques and NFTs.  
 
Table 2 Clinical data from iNPH patients 
 # Gender Age Comorbidities MMSE 
Aβ-/tau- 
1 F 75 NI 22 
2 F 76 NI 23 
3 F 77 NI 25 
4 M 75 NI 19 
Aβ+/tau- 
5 M 86 LBD/VaD 13 
6 F 79 NI 24 
7 M 79 NI 19 
8 F 71 NI 20 
9 F 76 NI 23 
Aβ+/tau+ 
10 F 78 NI 23 
11 F 77 NI 28 
12 F 74 NI 24 
13 M 79 AD/VaD 14 
14 F 81 AD 15 
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3.3 HUMAN POST-MORTEM FRONTAL CORTICES  
Post-mortem frontal cortices were obtained from the Karolinska Institutet 
Brain bank for Study II. A total of 4 non-demented controls and 4 patients carrying 
the FAD APPSwe mutation were used. Frozen tissues were cut in small pieces and 
homogenised in a 5cm3 glass-Teflon (1200rpm, 12 strokes) in digestion solution 
(RIPA, PIC and PPI). After homogenisation samples were left on ice for 10 min and 
quickly homogenised again and spun down at 7000g for 10 min at 4oC degrees to 
remove debris. Supernatant was collected and protein concentration determined by 
BCA. All the procedure was done on ice. 
 
Table 3 Clinical data from post-mortem FAD patients 
 # 
Age of 
 death 
Sex PMT 
Clinical 
diagnosis 
Age of 
onset 
Control 
1 82 F 9h CV - 
2 80 M 16h CV - 
3 67 M 21h CV - 
4 68 M 27h CV, pneumonia - 
APPSwe 
1 62 M 40h AD 53 
2 66 M 24h AD 61 
3 56 M 24h AD 44 
4 62 F 24h AD 51 
PMT – post-mortem time, CV - cardiovascular 
3.4 CELL MODELS  
Two different immortal cell lines were used in this thesis: Human embryonic 
kidney (HEK) 293 cells [(WT and stably expressing human APPSwe (gift of Dr Johan 
Lundkvist)] for Study III and mouse embryonic fibroblasts (MEF) cells for Study IV. 
Both cell lines were grown in DMEM supplemented with 10% Foetal Bovine Serum 
(FBS). Cells were grown in T75 flaks and split every 2-3 day when confluency was 
between 70 to 90%. No antibiotics were used except for HEK293 APPSwe where 
Zeocin (100µg/mL) was used to preserve the selection. 
For Study II primary neuronal cells (PCN) derived from E15-16 mouse 
embryonic cortices were used. PCN were seeded in Poly-D-lysine coated plates in 
Neurobasal supplemented with 1% (%V/V) L-Glutamine and 2% B-27, media 
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changed after one week (half of conditional media and half of new media) and usually 
treated/lysed/fixed at DIV13-15 were. 
3.5 CELLULAR EXPOSURE TO AMYLOID β-PEPTIDE 
Aβ1-42 (AnaSpec, #AS-24224) was prepared according to the manufacturer’s 
instructions to a stock solution of 5mM. Monomeric and oligomeric Aβ42 were 
prepared according to 312 and added to PCN for 24 hours (2µM) with or without 
scFvA13 (40nM). The intrabody scFvA13 was used to target oAβ and silence its 
function.313 Monomeric Aβ42 was prepared by directly dissolving stock Aβ42 to final 
concentration of 1mM. Oligomeric Aβ42 was prepared in the same way but left at 
4°C for 24h and then added to the cells.  
3.6 CELL STARVATION AND AUTOPHAGOSOME QUANTIFICATION 
Amino acid starvation has been widely used as a method to induce autophagy. 
PCN were deprived from amino acids and serum by changing the growing media 
(Neurobasal supplemented with L-glutamine and B-27) to Early’s Balance Salt 
Solution (EBSS) for 30 minutes, 1h, 1h30, 2h, 2h30 or 3h.  
Upon starvation, autophagosome were quantified by measuring LC3-I and 
LC3-II levels. The conjugation system LC3 has been widely used as an indirect 
measure of the amount of autophagosomes since it is the only protein that binds to 
the phagofore and remains attached during the matured autophagosome, only being 
degraded when autophagolysoosme is formed. LC3 exists in two forms: LC3-I and 
LC3-II (the last one is the lipidated form conjugated with PE). Only the last form 
integrates into autophagosome membrane, thus the levels of this protein are an 
indirect measure of the amount of autophagosomes. LC3-II form is larger in mass 
than LC3-I but it migrates faster in SDS-PAGE gels due to its increase 
dhydrophobicity.213 
3.7 TRANSMISSION ELECTRON MICROSCOPE, MITOCHONDRIA PROFILE 
AND QUANTIFICATION OF NUMBER AND LENGTH OF MERCS 
Due to the proximity between MAM and OMM (<80 nm) conventional 
fluorescent microscope, which has a resolution limit of 200 nm, cannot be used. 
Therefore, Tecnai 12 BioTWIN TEM (FEI company, Eidnhoven, The Netherlands) 
was used in all four studies of this thesis to quantify number and length of MERCS, 
number and perimeter of mitochondria profiles and number of MERCS per 
mitochondrion. Samples started by being chemically fixed: brain biopsies in 1% 
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glutaraldehyde and 3.7% formaldehyde, mouse brain in 2% glutaraldehyde and 1% 
formaldehyde and cell lines and primary cortical neurons in 2.5% glutaraldehyde [% 
calculated using (V/V)]. The different ratios used were due to different features of the 
fixatives. While glutaraldehyde has a strong fixative power its diffusion throughout 
the sample is slow, therefore it is used for flat or thin samples (eg. cell cultures). For 
tissue samples, since it is required that the fixative diffuse faster to keep the integrity 
of the tissue for imaging, a mix of glutaraldehyde and formaldehyde is used. Even 
though formaldehyde has a weaker fixative power it diffuses quicker through the 
tissue, keeping its integrity while the glutaraldehyde slowly diffuses to the core of the 
tissue. After fixation, cells are incubated for 2h with 2% OsO4 and dehydrated in 
ethanol and acetone. They are then embedded in LX-112 resin (Ladd, Burlington,VT, 
USA) and ultrathin sections made using Leica Ultracut UCT (Leica, Wien, Austria). 
Samples are then contrasted with uranyl acetate followed by lead citrate and 
observed in TEM (100kV) and digital pictures taken with Veleta camera (Olympus 
Soft Imaging Solutions, GmbH, Münster, Germany) at a magnification of 20.500X. 
Number and length/perimeter of MERCS and mitochondria profiles was then 
calculated using the freehand tool at ImageJ software (National Institutes of Health, 
Bethesda, MD, USA). A MERCS was considered if the distance between ER and 
mitochondria is equal or small than 30 nm.  
3.8 ALAMARBLUE 
30 minutes before finishing cell treatment (siRNA or starvation), alamarBlueTM 
Cell Viability Reagent (resasurin, DAL1025, ThermoFisher) was added into the cell 
media and cells put back at 37°C, 5% CO2. Media, together with the alamarBlueTM 
reagent, were transferred to a black 96-well plate with a clear bottom and 
fluorescence measured (λEx= 530-560nm; λEm= 580-610nm). Cells were lysed, 
protein determined and fluorescent arbitrary units normalised to protein levels. 
3.9 MITOCHONDRIAL TOXGLO 
Cell membrane permeability to necrotic proteins and ATP levels were 
measured using the Mitochondrial ToxGlo kit (Promega) according to manufacturer’s 
protocol. MEF and HEK293 APPSwe were seeded in 96-well black plates with a clear 
bottom and siRNA treatment performed. After 48h, media was removed and the 
cytotoxicity reagent was added for 30 min at 37oC and fluorescence measured (λEx= 
485nm; λEm= 525nm). For ATP levels the ATP detection reagent was added and 
luminescence measured. 
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3.10 SEAHORSE 
WT derived PCN were grown in Seahorse XF96 microplate (#101085-004, 
Agilent) (26.000 cells per well) for 14 DIV. On 15 DIV, cells were starved with EBSS 
as before. During the last 30 minutes, cells were calibrated in media (pH=7.2-7.4) 
without sodium bicarbonate and phenol red, at 37°C and without CO2. Basal 
respiration and ATP production was then measured using Seahorse XFe96 Analyser 
(Agilent), according to Seahorse XF Cell Mito Stress Test Kit (Agilent) (final 
concentration: 1 μM Oligomycin, 1 μM FCCP, 0.5 μM Rotenone and Antimycin A) 
and values obtained normalised to the amount of protein.  
3.11 AEQUORIN CALCIUM MEASUREMENTS  
Apoaequorin, in the presence of the co-factor coelenterazine, originates 
aequorin. In the presence of Ca2+ this molecule induces the transformation of 
coelenterazine to coelenteramide, inducing coelenteramide release as well as the 
emission of photons. These photons can be detected by a photomultiplier (H7360-
01 Hamamatsu Photonics), the output of the amplifier/discriminators was then 
captured by a photon counter (C8855-01 Hamamatsu Photonics) and recorded for 
analysis by the software (Hamamatsu Photonics), allowing to determine the 
concentration of Ca2+ that bound to aequorin. Ca2+ concentration were calibrated as 
described before.314 In addition, by putting different protein tag in aequorin we can 
target the protein to different organelles in the cell. 
HEK293 APPSwe were seeded in poly-D coated coverslips and, after 24h, Mfn2 
siRNA treatment performed like mentioned before. Furthermore, cells were also co-
transfected with either cytosolic or mitochondrial aequorin cDNA. After 47h, 
coelenterazine (5µM) was added to the cells for 1h and coverslips put in the 
perfusion chamber and perfused with Krebs-Ringer modified buffer (KRB; 135mM 
NaCl, 5 mM KCl, 400µM KH2PO4, 1mM MgSO4, 20mM HEPES, 11mM Glucose, pH 
= 7.4, 37°C) supplemented with 1mM of CaCl2. Ca2+ release from ER was induced 
with a mix of ATP (100µM) and carbachol (CCH, 300µM) in KRB solution without 
CaCl2 and in the presence of EGTA (600µM). Cells were lysed and the remaining 
aequorin pool discharged using digitonin (100µM) in a hypotonic Ca2+-rich solution 
[CaCl2 (10mM) in H2O].  
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3.12 NEPRILYSIN ACTIVITY 
HEK 293 APPSwe cells were treated with siRNA as described before. After 48h, 
they were washed with 0.1 M MES (pH = 6.5) and incubated with substrate mix: 
protease inhibitor (#786-331; G-Biosciences, Maryland Heights, USA), 1 μM Z-Leu-
Leu-Leu-H (aldehyde) (#3175; Peptide Institute, Osaka, Japan), 0.5 mM Suc-Ala-
Ala-Phe-MCA (#S8758; Sigma-Aldrich, St. Louis, USA) with or without 10 μM 
thiorphan (#T6031; Sigma-Aldrich) for 1 hr at 37°C. Cells were then incubated with 
15 μM Phosphoramidon (#4082; Peptide Institute) and 0.14μL of LAPase (#L5006; 
Sigma-Aldrich) and reaction was stopped with 10 nM of EDTA and fluorescence was 
measured in a plate reader (λEx = 355 nm, λEm = 460 nm). Differences between 
substrate mix with and without thiorphan represent neprilysin activity. 
3.13 SUBCELLULAR FRACTIONATION 
Subcellular fraction was performed according to Hedskog et al. and Schreiner 
et al.55,315 Briefly, brains of 2-4 months old female mice were collected, dissected 
into smaller pieces and homogenized (1500rpm, 12 strokes). Part of this 
homogenization was collected (whole homogenate - WH) and kept on ice. First 
centrifugation was performed at 800g (5min), pellet discarded and centrifuged again 
to remove nuclei and cell debris (pellet). Supernatant was collected and centrifuged 
at 9000g (10min) and crude mitochondrial was obtained in the pellet and supernatant 
collected. Supernatant was further centrifuged at 20.000g (20min), pellet (plasma 
membrane) discarded and supernatant centrifuged again 100.000g (1h) to generate 
the fraction containing ER. The crude mitochondrial fraction was put onto a 30% 
Percoll gradient and centrifuged at 95.000g for separation of pure mitochondria 
(bottom orange fraction) and MAM (top cloudy white fraction). Samples were then 
solubilized in RIPA buffer (30 min), unsolubilized material spun down (4000g, 5 min) 
and protein levels measured with BCA. Protein levels were assessed by WB. The 
whole protocol was done on ice or at 4°C. 
3.14 PROXIMITY LIGATION ASSAY AND FLUORESCENCE MICROSCOPY 
MEF cells were seeded in the inner ring of a Poly-D-lysine coated 35-mm glass-
bottom plate (MatTek Corportation #P35G-0-20-C) for 24h. Cells were then fixed in 
4% (V/V) formaldehyde solution and permeabilized with 0.4% CHAPSO. PLA 
protocol was then performed according to Duolink PLA kit (Sigma-Aldrich). Briefly, 
cells were blocked with Duolink blocking solution for 30 min at 37°C, antibody pairs 
(IP3R3-TOM70 or IP3R3-TOM20) incubated for 1h at 37°C. Positive and negative 
  58 
controls were incubated with just one of the antibodies (IP3R3, TOM70 or TOM20). 
Specific plus and negative secondary antibodies bound to PLA oligonucleotides 
probe were added to the cells and incubated for 1h at 37°C. Positive controls were 
targeted with positive and negative probe of the same secondary species while 
negative controls were treated similarly to samples. The oligonucleotides on the PLA 
probes were then ligated (30min, 37°C), forming a DNA template that was amplified 
with fluorescence probes (100min, 37°C). F-actin was labelled with Alexa Fluor 488 
Phalloidin (Thermo Fisher Scientific) and samples mounted using Duolink Mounting 
Media with DAPI. Fluorescent dots were then observed with a confocal microscope 
(Nikon A1RSi point scanning confocal inverted microscope). Images were acquired 
using a 60x oil immersion objective and PLA signals quantified with Duolink 
ImageTool.  
3.15 STATISTICS AND CORRELATIONS 
All data as analysed using IBM SPSS Statistics 22 software (IMB Corportation). 
Data was evaluated for normal distribution using Kolmogorov-Sminorv test, Q-Q plot 
and histogram distribution; to compare two groups, if normally distributed, samples 
were compared by independent-samples t-test for statistical significance and, if not 
normally distributed, samples were compared by non-parametric Mann-Whitney U-
test. More than to two groups were compared with One-Way ANOVA. Unless stated 
all the values are expressed as mean ± SEM, n = corresponds to the number of 
independent experiments or individual samples/patients and each dot represents 
either the average of one independent experiment or an individual measure, * p < 
0.05 were considered to be significant, ** p <0.001. 
3.16 ETHICAL CONSIDERATION AND ETHICAL PERMITS 
All the studies in this thesis followed the declaration of Helsinki, the current 
European Law (Directive 2010/63/EU), local ethical board and the guidelines of 
Karolinska Institutet (KI) or of the university where the study/material was 
performed/obtained. For the animal work performed at KI in Study II and Study IV 
(WT, APPNL-F and APPNL-G-F) we used the ethical permit S53-14 and ID 407, 
APPSwe/Lon animals and respective controls were obtained from QPS Austria 
conformed the Austrian guidelines for the care and use of laboratory animals. For 
human post-mortem tissues (Study II) the study was done together with the KI Brain 
Bank under the ethical permit (2011/962-31/1) and for brain biopsies the Finnish 
ethical permit 5//2008 was used (Study I). 
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4 RESULTS AND DISCUSSION 
Four studies originated from this doctoral project. In the next section, I will 
describe the major conclusions and contributions of these studies to the field. 
4.1 STUDY I: ALTERATIONS IN MITOCHONDRIA-ENDOPLASMIC RETICULUM 
CONNECTIVITY IN HUMAN BRAIN BIOPSIES FROM IDIOPATHIC NORMAL 
PRESSURE HYDROCEPHALUS PATIENTS. 
Mitochondria contact sites (MCS) and MERCS have previously been visualised 
in several tissues, however no one had, to the best of our knowledge, shown their 
ultrastructure in the human brain.  In this study, we started by showing the presence 
of several mitochondria contact sites in human biopsies, including interactions with 
plasma membrane, nuclei, Golgi apparatus and lysosomes. The most common MCS 
observed were MERCS where 12.8 ± 0.5% of the mitochondrial surface was in 
contact with ER. We observed different types of MERCS; while some were just a 
punctate contact, others appeared as longer stretches. We also reported, for the first 
time, the presence of these MERCS in both pre- and post-synaptic terminals in 
human brains. Although the presence of MERCS in synapses has been described 
before in neurons from mice, the role of this subcellular region in synapses is still 
unknown.47 Currently our laboratory is studying the possible role of MERCS in 
synaptic dynamics. We hypothesise that both mitochondria and ER, as well as their 
interplay, have pivotal roles in synapses due to their importance in regulating Ca2+ 
and ATP homeostasis. 
Furthermore, in this study we showed that the number of MERCS was 
significantly increased in patients diagnosed with dementia [Lewy body dementia 
/vascular AD (VaD), AD/VaD or only AD], while the MERCS length was not altered. 
Similarly, the number and length of MERCS were also increased (even though not 
significant) in the group of patients with moderate or severe cognitive impairment 
(MMSE score was equal to or below 22) as compared to the no significant cognitive 
impairment group. In addition, the number of MERCS positively correlated with 
patient’s age. Although some significant data was obtained with this sample size, we 
believe that an increased sample size could lead to a better understanding how 
MERCS ultrastructure changes with the decrease of cognitive functions and ageing. 
Nevertheless, we show that the juxtaposition between mitochondria and ER 
increases with ageing and with dementia progression however, it is hard to 
distinguish between the effect of ageing itself and of dementia. In order to assess 
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this, access to samples from patients with the same age but different cognitive 
diagnosis would be required. 
Since it has been shown before that Aβ is formed in MERCS and that 
modulation of MERCS leads to changes in Aβ levels we believe that MERCS and 
Aβ formation are intrinsically connected. In this study, we observed a positive 
correlation between the number of MERCS and the ventricular levels of Aβ42, while 
no correlation was found with lumbar Aβ42 or with ventricular/lumbar total tau or 
phosphorylated tau (data now shown). Surprisingly, when we stratified the samples 
by the absence or presence of amyloid plaques and neurofibrillary tangles, we 
observed that MERCS length was decreased in the presence of both plaques and 
the tangles. Moreover, the % of distribution of MERCS was also shifted while patients 
without plaques and tangles had more than 50% of their MERCS length above 
200nm and 22.7% of below 50nm, patients with both plaques and tangles had 26.9% 
of MERCS length above 200nm and 40.5% of contacts below 50nm. In conclusion, 
we show, for the first time, the presence of MCS in human brain biopsies and that 
MERCS ultrastructure is increased in demented and aged patients. This study 
contributes to a better understanding of MERCS dynamics in human brain, both in 
pathological and non-pathological situations. 
4.2 STUDY II: AMYLOID β-PEPTIDE INCREASES MITOCHONDRIA-ER 
CONTACTS AND AFFECTS MITOCHONDRIAL FUNCTION AND 
AUTOPHAGOSOME FORMATION 
Although several studies have connected alterations in MERCS with AD the 
underlying mechanisms were not elucidated. Additionally, most of these studies 
used cells derived from AD patients with complex cellular alterations and 
overexpressing models (which can have mislocalisation of APP protein and other 
secondary effects) or even non-neuronal cell models (which either do not have 
functional mitochondria – Warburg effect – or are not exclusively OXPHOS-
dependent like neurons).53–55,275,305 Therefore, in this study we aimed to determine 
the effect of Aβ on MERCS protein expression and/or ultrastructure in post-mortem 
FAD brain; cortex and CA1 of APPSwe, APPNL-F and APPNL-G-F mouse models; and 
primary cortical mouse neurons treated with difference Aβ species. 
We started by analysing the expression of MERCS proteins in post-mortem 
frontal cortex of FAD patients carrying the Swedish mutation. We selected this 
mutation because, as mentioned before, it leads to an increase of Aβ levels, more 
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specifically Aβ40 and Aβ42. We discovered that both Mfn1 and Mfn2 levels were 
significantly decreased as well as TOM70, cytochrome c and TIM23 levels. This data 
supports previous data showing an increase in mitochondria fragmentation in SAD266 
and suggests that MERCS ultrastructure/function could be altered. However, since 
we did not have access to fixed post-mortem samples, we decided to assess 
MERCS ultrastructure in other models. We decided to use three different mouse 
models that, similarly to the post-mortem samples, presented increased levels of Aβ: 
the overexpressing model APPSwe and the KI models APPNL-F and APPNL-G-F. Overall, 
all these models showed an increase in the number of MERCS per mitochondria. 
Furthermore, the KI models also showed an increased number of mitochondrial 
profiles and da ecrease of the mitochondrial perimeter, suggesting that mitochondria 
are more fragmented in these models. Similar results were found in PCN derived 
from WT and APPNL-F, where the KI model derived PCN showed an increased 
number and length of MERCS, as well as an increased number of mitochondrial 
profiles. In addition, preliminary data showed that also MERCS-related proteins (eg. 
Mfn2) are also altered also in APPNL-F-derived PCN. We further confirmed this data 
by incubating WT PCN with synthetic Aβ42 (both monomeric and oligomeric, mAβ42 
and oAβ42 respectively). Similarly, as observed in the APPNL-F derived PCN, we 
observed an increase in the number of MERCS upon incubation with mAβ42. 
However, when normalising the number of MERCS to number of mitochondria, we 
observed an increase in both the mAβ42 and oAβ42. Therefore, we decided to 
assess if MERCS-related proteins are affected in cells incubated with mAβ42 and 
indeed Mfn2 levels were downregulated as shown in other models. 
Since autophagosomes can be formed at MERCS we decided to investigate if 
the increase in MERCS had an effect on autophagosome formation. We started by 
evaluating basal autophagy in WT- and APPNL-F-derived PCN, where we observed 
an increase in LC3B-II and a decrease in p62 protein levels, in the KI model 
suggesting up-regulation of autophagy. Thereafter, we starved both WT- and APPNL-
F-derived PCN and observed that autophagosomes were formed faster in the KI 
model than in WT. Interestingly, the number of MERCS per mitochondria was 
increased right before autophagosome formation in each model and Mfn2 and 
VDAC1 protein levels were altered. Therefore, we hypothesise that the increased 
connectivity between ER and mitochondria is needed for the formation of mature 
autophagosomes. ATP has been shown to be essential for autophagosome 
formation and thus we decided to assess mitochondrial function during the starvation 
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process. Indeed, we observed that starved WT PCN showed an increase in basal 
respiration, ATP production and ΔΨm at the same time as the number of MERCS 
per mitochondrian are increased.  
This data suggests a new mechanism as to how Aβ affects cell homeostasis. 
We show that Aβ itself increases both the number of MERCS and number of MERCS 
per mitochondria, affecting mitochondrial function and autophagosome formation. 
Furthermore, we show, for the first time, that autophagosome formation during 
starvation leads to the increased proximity between ER and mitochondria and 
upregulation of mitochondria function. Further characterisation in PCN derived from 
APPNL-F will be performed in order to understand how Aβ alters autophagosome 
formation as well as mitochondrial function and dynamics. 
4.3 STUDY III: MITOFUSIN-2 KNOCKDOWN INCREASES ER-MITOCHONDRIA 
CONTACT AND DECREASES AMYLOID β-PEPTIDE PRODUCTION 
Since we observed that MERCS are altered in AD and that Aβ is formed in 
MERCS we decided to evaluate if modulation of MERCS affected Aβ levels. In order 
to modulate MERCS, we decided to KD Mfn2 in HEK293 cells overexpressing 
APPSwe. Due to the pivotal role of Mfn2 in cell homeostasis, we first assessed cell 
viability and we observed no differences in cytosolic reducing power or plasma 
membrane permeability upon KD of Mfn2. Since Mfn2 KD could affect mitochondrial 
dynamics and bioenergetics we also decided to assess ATP levels. No differences 
were detected in ATP levels upon acute KD of Mfn2. We believe this could be related 
to a compensation mechanism since, although not significant, we observed an 
increase in Mfn1 expression upon Mfn2 KD. However, upon ablation of Mfn2, we 
saw a significant increase in MERCS length and percentage of mitochondrial surface 
in contact with ER. This data was confirmed by the observation that ER-mitochondria 
Ca2+-transfer was increased upon induction of Ca2+ release from ER using ATP and 
carbachol. Interestingly, the reduction of Mfn2 levels led to decrease of both intra- 
and extracellular levels of Aβ40 and Aβ42 coupled to impaired g-secretase assembly 
and decreased activity (measured by the production of AICD). No changes were 
found in neprilysin activity (major Ab degrading protein).  
This data was surprising since we observed in Study I and Study II that an 
increase in Aβ is connected to an increase in MERCS. However, in this study, acute 
increase in MERCS leads to a decrease in Aβ levels. Several explanations could be 
considered: the fact that in the first studies we evaluated MERCS ultrastructure in 
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increased Aβ models, whereas in this study we modulated MERCS and evaluated 
Aβ; the fact that in the present study we performed an acute MERCS modulation 
while the models on Study I and Study II we measure MERCS in basal conditions; 
the model used in the present study is an immortalised cell lines derived from kidney 
cells while in the previous studies brain or primary cultures were used which have, 
as mentioned before, a substantially different mitochondrial metabolism. However, I 
believe that the observed discrepancy is connected to the inhibition of Aβ formation 
by MERCS (Figure 8). Under normal conditions, Aβ is formed, among other places, 
in MERCS. When the levels of the peptide increase, this leads to an increase in the 
connectivity between ER and mitochondria (probably via Mfn2), which results in an 
inhibition of Aβ production, in a negative regulation feedback (similarly to what was 
observed in autophagosomes220), at least during the time frame studied. This 
mechanism would allow MERCS to regulate Aβ levels, lowering its levels when they 
are too high. Our data supports partly this model since all the models with increased 
Aβ we studied showed a decrease in Mfn2 levels and an increase in the number of 
MERCS. Furthermore, the increased number of MERCS observed in AD could be a 
rescue mechanism where the cells are trying to reduce the elevated levels of Aβ. 
Regardless of the exact unknown mechanism, our data reveals a new mechanism 
in which we show that modulation of MERCS alters Aβ formation. This new cellular 
pathway could be of great importance in understanding the mechanisms underlying 
the role of MERCS in AD. 
4.4 STUDY IV: TOM70 SUSTAINS CELL BIOENERGETICS BY PROMOTING 
IP3R3 - MEDIATED ER TO MITOCHONDRIA Ca2+ TRANSFER 
Previous findings showed that Aβ is imported into mitochondria via the 
translocase of the outer membrane (TOM)247 and that Aβ is partially generated in 
MAM.52 Therefore, we hypothesise whether TOM proteins are localised in MERCS 
and, if so, what their role is in this subcellular region. We started by showing that 
whilst TOM70 formed specific cluster along the OMM, TOM20 was ubiquitously 
covering most of the mitochondrial network. Curiously, TOM70 clusters were 
frequently co-localized with the ER, hinting that TOM70 is present in the OMM in 
proximity of MAM. In fact, we showed that both TOM70 and 20 are present in MAM-
OMM-enriched subcellular fractions, that they are in close proximity with IP3R3 (as 
observed by PLA) and that they also co-precipitate with IP3R3 showing that these 
OMM proteins are not only close to MAM but also interact with MAM-related protein 
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IP3R3. Interestingly, we also found that upon knockdown of TOM70, but not of 
TOM20, there was a decrease in IP3-dependent Ca2+ release from ER to 
mitochondria and a decrease in Ca2+ levels inside mitochondria, suggesting a 
possible alteration and decrease in the contacts between ER and mitochondria. 
Surprisingly, when we assessed MERCS upon siRNA knockdown of TOM70 using 
both immunocytochemistry and TEM, no differences were found in MERCS. 
Curiously, since endogenous levels of IP3R3 where changed after TOM70 KD, we 
assessed IP3R3 distribution and we found less IP3R3 co-localizing with the OMM 
and less interaction between IP3R3-Grp75.  
Altogether, this data suggests that TOM70 has a role in recruiting and/or 
stabilising IP3R3 localisation at MERCS but does not act as a scaffolding protein 
itself. To our knowledge, this is the first time that a protein has been shown to affect 
MERCS function without altering its ultrastructure. (Figure 7). A decrease in 
mitochondrial Ca2+ leads to changes in mitochondrial respiration and TCA cycle, 
affecting ATP formation and consequently decrease of cell number and induction of 
autophagy. Currently, we do not know if TOM70 also has a role in the import of Aβ 
through the OMM. TOM70 is only transiently associated to the TOM complex 
therefore it is possible that the role of TOM70 in recruiting IP3R3 to MAM is 
independent from its function in the protein import machinery.  
 
Figure. 7 Graphical Abstract of Study IV. KD of TOM70 leads to decreased in Ca2+ shuttling from the 
ER to mitochondria, cell proliferation, and mitochondrial activity, increase in autophagy and alteration 
in localisation of IP3R3 in MAM. (from Filadi et al. 2018, Current Biology) 
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5 CONCLUDING REMARKS AND FUTURE WORK 
 
AD is the most common form of dementia in the world and, as of today, there 
are still drugs that can stop the progression of the disease. Several clinical trials to 
find a drug that stops the ongoing neurodegeneration process have failed.  Therefore, 
researchers are currently focusing on developing multi-target therapies. The 
remaining issue is that several mechanisms and pathways connected to AD remain 
unknown. Therefore, there is a need to further understand the molecular 
mechanisms underlying the pathology, specifically the ones underlying the formation 
of the pathology hallmarks.  
 
The aim of this thesis was to further understand the role of mitochondria-ER 
contact sites in AD. Even though MERCS were first described in 1990 it was not until 
2009 that a connection between this subcellular region and AD was established. This 
allowed the connection of several of the biological processes altered in AD to one 
site within the cell (eg. altered glucose metabolism, Ca2+ homeostasis, 
autophagosome formation/maturation, phospholipid and lipid metabolism). Although, 
some new evidence has emerged over the years, we still do not know if alteration in 
MERCS is a cause or consequence of AD. Further,ore, how Aβ and MERCS regulate 
each other remains elusive. What we do know, together with previously published 
articles and the studies in this thesis, is that they are intrinsically connected. This 
thesis contributes to the field by showing that: 
• during ageing there is an increase in the number of MERCS as well as in 
demented patients showing that MERCS dynamics change not only in 
pathology but also with the normal ageing; 
• the number of MERCS positively correlated with the levels of ventricular 
Aβ42 and models with increased Aβ levels show an increment in MERCS, 
a decrease of Mfn2 protein levels and alterations in mitochondria function 
and autophagosome formation; 
• as increase of MERCS (by Mfn2-KD) leads to a decrease of Aβ formation; 
• it is possible to modulate Ca2+ activity in MERCS without changing its 
ultrastructure by modulating TOM70 protein levels.  
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Even though this thesis could not answer whether the increased in MERCS is a 
cause or a consequence of the unbalanced Aβ formation in AD, it certainly helped 
to understand better of the mechanisms underlying. Based on the data above we 
believe that MERCS have a pivotal role in AD and cell homeostasis. In fact, levels of 
MERCS are increased in different AD models with increased Aβ levels. In addition, 
inhibition of oAβ with scFvA13 rescue the numbers of MERCS similarly to the control 
showing that oAβ itself modulates MERCS. Consistently, the levels of the MERCS 
negative regulator Mfn2 were decreased in all the Aβ models analysed, which could 
explain the observed increment of MERCS. In fact, Mfn2 knock-down led to an 
increase of MERCS length and reduction in the levels of Aβ. Therefore, we 
hypothesise a new model where Aβ affects MERCS via Mfn2 although we were 
unable to identify the exact mechanism (Figure 8). Although this data seems 
contradictory at the first sight, we believe that this oppsoing data is a result of a a 
negative feedback mechanism from MERCS to Aβ. Our hypothesis is that Aβ is 
formed, among other places, in MERCS. However, at high concentration, Aβ induced 
an increase in the connectivity between ER and mitochondria (as observed in Study 
II). This increment in MERCS leads to the ceasing of Aβ formation either through 
modulation of APP processing and g-secretase assembly/activity in MERCS (as 
observed in Study III) and/or its degradation/secretion via 
exosome/autophagosomes (Figure 8). Additionally, since Aβ leads to general cell 
failure, the augmentation of MERCS could be a cellular rescue mechanism since it 
would try to re-establish normal cell metabolism and biological functions. However, 
prolonged increase of MERCS (as a result of to constant high levels of Aβ) can 
ultimately result into cell death (eg. apoptosis) due to subsequent mitochondrial Ca2+ 
overload and alteration in autophagosome formation/maturation. 
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Figure. 8 Under normal conditions there is a balance between Aβ, Mfn2 levels and MERCS. In 
pathological conditions, an increase in Aβ, decrease in Mfn2 and an increase of number of MERCS 
is observed. How MERCS regulate Aβ levels is not known but we believe that a negative feedback 
loop could be involved in this process 
 
Therefore, this thesis contributes to a better understanding of how MERCS 
regulates and is regulated in AD. Although, since the field of MCS and MERCS is 
still in its early days, I believe that, before we clearly understand the mechanisms 
behind MERCS in AD pathology, further progress will require a better understanding 
in the basic knowledge of MERCS: Are there different types of MERCS? If yes, do 
these different types have different tethering proteins? If so which ones are affected 
in AD? Do they have different functions? Does the MAM have a different 
composition? Does the composition of MAM change during different metabolic 
conditions? What are the signals that promote the proximity between ER and 
mitochondria? After we understand these basics and the consequences of MERCS 
modulation, we can then start thinking about MERCS as a possible target for drug 
treatment.  
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